| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.566 | 0.018 | 0.566 | 5 Hydroxytryptamine release stimulant | 0.215 0.109 DBMET03339 0.222 0.105 DBMET03340 0.255 0.087 DBMET03341 0.526 0.023 DBMET03342 0.563 0.018 DBMET03343 0.563 0.018 DBMET03344 0.481 0.03 DBMET03345 0.249 0.089 DBMET03346 0.457 0.035 DBMET03347 0.249 0.089 DBMET03349 0.457 0.035 DBMET03350 0.192 0.128 DBMET03351 0.358 0.055 DBMET03352 | ||
| 0.498 | 0.016 | 0.71 | Vasodilator, coronary | 0.413 0.031 DBMET03339 0.324 0.07 DBMET03340 0.437 0.026 DBMET03341 0.499 0.015 DBMET03342 0.436 0.026 DBMET03343 0.44 0.025 DBMET03344 0.498 0.016 DBMET03345 0.255 0.13 DBMET03346 0.694 0.005 DBMET03347 0.257 0.127 DBMET03349 0.698 0.005 DBMET03350 0.264 0.121 DBMET03351 0.71 0.004 DBMET03352 | DBMET03352 | |
| 0.518 | 0.053 | 0.604 | Caspase 9 stimulant | 0.381 0.123 DBMET03339 0.308 0.185 DBMET03340 0.376 0.126 DBMET03341 0.456 0.08 DBMET03342 0.561 0.042 DBMET03343 0.489 0.064 DBMET03344 0.579 0.039 DBMET03345 0.276 0.221 DBMET03346 0.604 0.036 DBMET03347 0.514 0.054 DBMET03350 0.517 0.053 DBMET03352 | DBMET03347 | |
| 0.428 | 0.005 | 0.455 | Tumour necrosis factor antagonist | 0.358 0.01 DBMET03339 0.175 0.071 DBMET03340 0.455 0.005 DBMET03341 0.36 0.009 DBMET03342 0.385 0.007 DBMET03343 0.387 0.007 DBMET03344 0.372 0.008 DBMET03345 0.185 0.063 DBMET03346 0.157 0.092 DBMET03347 0.164 0.083 DBMET03349 0.136 0.118 DBMET03350 0.164 0.083 DBMET03351 0.202 0.052 DBMET03352 | DBMET03341 | |
| 0.456 | 0.039 | 0.487 | Vasodilator, peripheral | 0.378 0.063 DBMET03339 0.291 0.101 DBMET03341 0.42 0.049 DBMET03342 0.47 0.035 DBMET03343 0.395 0.057 DBMET03344 0.468 0.035 DBMET03345 0.216 0.158 DBMET03346 0.487 0.031 DBMET03347 0.417 0.05 DBMET03350 0.476 0.033 DBMET03352 | DBMET03347 | |
| 0.425 | 0.017 | 0.425 | Calcium channel activator | 0.412 0.02 DBMET03339 0.258 0.138 DBMET03340 0.321 0.072 DBMET03341 0.319 0.074 DBMET03342 0.412 0.02 DBMET03343 0.384 0.031 DBMET03344 0.378 0.034 DBMET03345 0.285 0.107 DBMET03346 0.253 0.144 DBMET03349 0.246 0.152 DBMET03351 | ||
| 0.455 | 0.058 | 0.462 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.462 0.054 DBMET03339 0.362 0.138 DBMET03340 0.395 0.105 DBMET03341 0.415 0.088 DBMET03342 0.383 0.116 DBMET03343 0.383 0.116 DBMET03344 0.383 0.116 DBMET03345 0.295 0.219 DBMET03346 0.295 0.219 DBMET03349 0.295 0.219 DBMET03351 | DBMET03339 | |
| 0.424 | 0.037 | 0.492 | Caspase 3 stimulant | 0.434 0.034 DBMET03339 0.27 0.097 DBMET03340 0.318 0.071 DBMET03341 0.427 0.036 DBMET03342 0.34 0.062 DBMET03343 0.417 0.04 DBMET03344 0.443 0.031 DBMET03345 0.384 0.049 DBMET03347 0.492 0.021 DBMET03350 0.406 0.043 DBMET03352 | DBMET03350 | |
| 0.407 | 0.022 | 0.479 | Antimitotic | 0.383 0.026 DBMET03339 0.415 0.021 DBMET03340 0.417 0.021 DBMET03341 0.479 0.014 DBMET03342 0.393 0.024 DBMET03343 0.281 0.049 DBMET03344 0.364 0.029 DBMET03345 0.276 0.051 DBMET03346 0.19 0.09 DBMET03347 0.431 0.019 DBMET03351 0.169 0.105 DBMET03352 | DBMET03342 | |
| 0.395 | 0.028 | 0.468 | Superoxide dismutase inhibitor | 0.216 0.101 DBMET03339 0.181 0.141 DBMET03340 0.25 0.074 DBMET03341 0.238 0.082 DBMET03342 0.456 0.018 DBMET03343 0.456 0.018 DBMET03344 0.468 0.016 DBMET03345 0.418 0.024 DBMET03346 0.418 0.024 DBMET03349 0.336 0.04 DBMET03351 | DBMET03345 | |
| 0.388 | 0.033 | 0.488 | Hypoxia-inducible factor 1 alpha inhibitor | 0.257 0.094 DBMET03339 0.243 0.107 DBMET03340 0.296 0.067 DBMET03341 0.4 0.03 DBMET03342 0.458 0.019 DBMET03343 0.488 0.016 DBMET03344 0.475 0.017 DBMET03345 0.18 0.178 DBMET03346 0.432 0.023 DBMET03347 0.201 0.15 DBMET03349 0.461 0.018 DBMET03350 0.181 0.177 DBMET03351 0.446 0.021 DBMET03352 | DBMET03344 | |
| 0.355 | 0.012 | 0.355 | Alpha adrenoreceptor antagonist | 0.24 0.021 DBMET03339 0.123 0.046 DBMET03341 0.32 0.014 DBMET03342 0.199 0.028 DBMET03343 0.216 0.025 DBMET03344 0.282 0.017 DBMET03345 0.102 0.056 DBMET03346 0.111 0.051 DBMET03349 0.101 0.056 DBMET03351 | ||
| 0.342 | 0.008 | 0.438 | NADPH oxidase inhibitor | 0.213 0.03 DBMET03339 0.114 0.091 DBMET03340 0.302 0.012 DBMET03341 0.358 0.006 DBMET03342 0.42 0.005 DBMET03343 0.438 0.005 DBMET03344 0.411 0.005 DBMET03345 0.159 0.049 DBMET03346 0.421 0.005 DBMET03347 0.119 0.084 DBMET03349 0.349 0.007 DBMET03350 0.356 0.007 DBMET03352 | DBMET03344 | |
| 0.34 | 0.006 | 0.34 | Alpha 2 adrenoreceptor antagonist | 0.164 0.024 DBMET03339 0.104 0.045 DBMET03341 0.292 0.009 DBMET03342 0.214 0.016 DBMET03343 0.238 0.012 DBMET03344 0.316 0.007 DBMET03345 0.077 0.071 DBMET03346 0.086 0.059 DBMET03349 0.08 0.066 DBMET03351 | ||
| 0.355 | 0.024 | 0.441 | 5 Hydroxytryptamine uptake stimulant | 0.224 0.112 DBMET03339 0.225 0.109 DBMET03340 0.441 0.008 DBMET03341 0.366 0.021 DBMET03342 0.368 0.021 DBMET03343 0.368 0.021 DBMET03344 0.385 0.017 DBMET03345 0.227 0.107 DBMET03346 0.227 0.107 DBMET03349 0.207 0.139 DBMET03351 | DBMET03341 | |
| 0.355 | 0.033 | 0.484 | Amyloid beta aggregation inhibitor | 0.215 0.07 DBMET03339 0.171 0.094 DBMET03340 0.321 0.041 DBMET03341 0.4 0.025 DBMET03342 0.478 0.016 DBMET03343 0.484 0.015 DBMET03344 0.464 0.018 DBMET03345 0.336 0.038 DBMET03347 0.373 0.029 DBMET03350 0.269 0.052 DBMET03352 | DBMET03344 | |
| 0.316 | 0.006 | 0.316 | Alpha 2c adrenoreceptor antagonist | 0.24 0.011 DBMET03339 0.095 0.071 DBMET03340 0.198 0.019 DBMET03341 0.311 0.006 DBMET03342 0.206 0.017 DBMET03343 0.238 0.012 DBMET03344 0.261 0.009 DBMET03345 0.084 0.082 DBMET03346 0.105 0.062 DBMET03349 0.089 0.076 DBMET03351 | ||
| 0.313 | 0.004 | 0.322 | Calcium antagonist | 0.259 0.007 DBMET03339 0.227 0.01 DBMET03340 0.28 0.005 DBMET03341 0.322 0.004 DBMET03342 0.197 0.014 DBMET03343 0.201 0.013 DBMET03344 0.206 0.013 DBMET03345 0.121 0.035 DBMET03346 0.123 0.033 DBMET03349 0.126 0.032 DBMET03351 | DBMET03342 | |
| 0.321 | 0.017 | 0.376 | Tubulin antagonist | 0.269 0.023 DBMET03339 0.376 0.013 DBMET03340 0.281 0.021 DBMET03341 0.365 0.014 DBMET03342 0.301 0.019 DBMET03343 0.206 0.035 DBMET03344 0.3 0.019 DBMET03345 0.138 0.064 DBMET03346 0.242 0.026 DBMET03351 | DBMET03340 | |
| 0.326 | 0.032 | 0.528 | Cyclic AMP phosphodiesterase inhibitor | 0.329 0.031 DBMET03339 0.172 0.12 DBMET03341 0.338 0.029 DBMET03342 0.268 0.055 DBMET03343 0.287 0.047 DBMET03344 0.326 0.032 DBMET03345 0.466 0.009 DBMET03347 0.483 0.008 DBMET03350 0.528 0.005 DBMET03352 | DBMET03352 | |
| 0.305 | 0.014 | 0.323 | 5 Hydroxytryptamine 2B antagonist | 0.164 0.035 DBMET03339 0.246 0.019 DBMET03340 0.115 0.066 DBMET03341 0.323 0.013 DBMET03342 0.159 0.037 DBMET03343 0.204 0.026 DBMET03344 0.192 0.028 DBMET03345 0.104 0.078 DBMET03349 | DBMET03342 | |
| 0.338 | 0.057 | 0.535 | Aldehyde oxidase inhibitor | 0.179 0.117 DBMET03339 0.186 0.112 DBMET03340 0.222 0.094 DBMET03341 0.523 0.03 DBMET03342 0.508 0.032 DBMET03343 0.406 0.046 DBMET03344 0.535 0.028 DBMET03345 | DBMET03345 | |
| 0.291 | 0.012 | 0.291 | Alpha 1 adrenoreceptor antagonist | 0.229 0.017 DBMET03339 0.116 0.038 DBMET03341 0.255 0.014 DBMET03342 0.155 0.028 DBMET03343 0.166 0.026 DBMET03344 0.208 0.02 DBMET03345 | ||
| 0.298 | 0.035 | 0.48 | Platelet adhesion inhibitor | 0.236 0.054 DBMET03339 0.209 0.066 DBMET03341 0.224 0.059 DBMET03342 0.288 0.038 DBMET03343 0.325 0.026 DBMET03344 0.316 0.029 DBMET03345 0.354 0.019 DBMET03346 0.48 0.006 DBMET03347 0.375 0.014 DBMET03349 0.451 0.008 DBMET03350 0.371 0.015 DBMET03351 0.46 0.007 DBMET03352 | DBMET03347 | |
| 0.303 | 0.04 | 0.323 | Ca(v)3.3 blocker | 0.27 0.073 DBMET03339 0.271 0.072 DBMET03340 0.286 0.055 DBMET03341 0.323 0.026 DBMET03342 0.25 0.1 DBMET03343 0.202 0.189 DBMET03344 0.227 0.139 DBMET03345 0.223 0.147 DBMET03346 0.198 0.195 DBMET03351 | DBMET03342 | |
| 0.38 | 0.123 | 0.6 | Apoptosis agonist | 0.333 0.149 DBMET03339 0.372 0.128 DBMET03341 0.44 0.095 DBMET03342 0.449 0.092 DBMET03343 0.434 0.098 DBMET03344 0.447 0.093 DBMET03345 0.599 0.049 DBMET03347 0.6 0.049 DBMET03350 0.337 0.147 DBMET03351 0.589 0.052 DBMET03352 | DBMET03350 | |
| 0.27 | 0.016 | 0.27 | Antiadrenergic | 0.164 0.032 DBMET03339 0.085 0.066 DBMET03340 0.192 0.026 DBMET03342 0.181 0.028 DBMET03343 0.193 0.025 DBMET03344 0.223 0.02 DBMET03345 0.077 0.074 DBMET03346 0.083 0.068 DBMET03349 | ||
| 0.263 | 0.008 | 0.266 | Alpha 2a adrenoreceptor antagonist | 0.14 0.024 DBMET03339 0.079 0.049 DBMET03341 0.222 0.011 DBMET03342 0.173 0.018 DBMET03343 0.216 0.012 DBMET03344 0.266 0.008 DBMET03345 0.068 0.06 DBMET03349 | DBMET03345 | |
| 0.265 | 0.011 | 0.265 | Alpha 1a adrenoreceptor antagonist | 0.213 0.015 DBMET03339 0.1 0.036 DBMET03341 0.215 0.015 DBMET03342 0.13 0.027 DBMET03343 0.138 0.025 DBMET03344 0.176 0.019 DBMET03345 | ||
| 0.268 | 0.015 | 0.268 | Adrenaline antagonist | 0.161 0.032 DBMET03339 0.083 0.066 DBMET03340 0.189 0.026 DBMET03342 0.179 0.028 DBMET03343 0.191 0.025 DBMET03344 0.22 0.02 DBMET03345 0.075 0.073 DBMET03346 0.081 0.067 DBMET03349 | ||
| 0.274 | 0.026 | 0.314 | I kappa B kinase epsilon inhibitor | 0.216 0.058 DBMET03339 0.314 0.01 DBMET03340 0.275 0.025 DBMET03341 0.258 0.034 DBMET03342 0.263 0.031 DBMET03343 0.234 0.046 DBMET03344 0.261 0.032 DBMET03345 | DBMET03340 | |
| 0.26 | 0.013 | 0.26 | Alpha 2b adrenoreceptor antagonist | 0.203 0.023 DBMET03339 0.16 0.035 DBMET03341 0.24 0.016 DBMET03342 0.168 0.032 DBMET03343 0.2 0.024 DBMET03344 0.225 0.019 DBMET03345 | ||
| 0.269 | 0.024 | 0.331 | Cholinergic | 0.155 0.073 DBMET03339 0.21 0.042 DBMET03340 0.195 0.049 DBMET03341 0.331 0.015 DBMET03342 0.217 0.039 DBMET03343 0.214 0.041 DBMET03344 0.206 0.044 DBMET03345 | DBMET03342 | |
| 0.29 | 0.053 | 0.457 | Interleukin agonist | 0.28 0.059 DBMET03339 0.164 0.154 DBMET03340 0.242 0.085 DBMET03341 0.261 0.071 DBMET03342 0.299 0.048 DBMET03343 0.299 0.048 DBMET03344 0.313 0.042 DBMET03345 0.457 0.012 DBMET03347 0.457 0.012 DBMET03350 0.428 0.015 DBMET03352 | DBMET03350 | |
| 0.27 | 0.036 | 0.35 | P-glycoprotein inhibitor | 0.292 0.03 DBMET03339 0.257 0.039 DBMET03340 0.252 0.041 DBMET03341 0.35 0.021 DBMET03342 0.221 0.053 DBMET03343 0.219 0.053 DBMET03344 0.231 0.048 DBMET03345 0.207 0.06 DBMET03347 0.196 0.066 DBMET03350 0.22 0.053 DBMET03352 | DBMET03342 | |
| 0.249 | 0.021 | 0.309 | Acetylcholinesterase inhibitor | 0.147 0.057 DBMET03339 0.23 0.025 DBMET03340 0.195 0.034 DBMET03341 0.309 0.012 DBMET03342 0.214 0.029 DBMET03343 0.211 0.03 DBMET03344 0.203 0.032 DBMET03345 0.116 0.082 DBMET03346 0.106 0.095 DBMET03349 | DBMET03342 | |
| 0.345 | 0.12 | 0.46 | 5 Hydroxytryptamine release inhibitor | 0.29 0.177 DBMET03339 0.246 0.234 DBMET03340 0.292 0.174 DBMET03341 0.283 0.185 DBMET03342 0.348 0.117 DBMET03343 0.348 0.117 DBMET03344 0.32 0.144 DBMET03345 0.46 0.047 DBMET03347 0.46 0.047 DBMET03350 0.429 0.062 DBMET03352 | DBMET03350 | |
| 0.267 | 0.057 | 0.297 | 5 Hydroxytryptamine 1E antagonist | 0.175 0.16 DBMET03339 0.297 0.032 DBMET03342 0.249 0.075 DBMET03343 0.249 0.075 DBMET03344 0.256 0.068 DBMET03345 0.197 0.135 DBMET03346 0.197 0.135 DBMET03349 0.173 0.162 DBMET03351 | DBMET03342 | |
| 0.254 | 0.05 | 0.424 | Platelet aggregation inhibitor | 0.249 0.052 DBMET03339 0.424 0.016 DBMET03340 0.219 0.068 DBMET03341 0.255 0.049 DBMET03342 0.192 0.087 DBMET03343 0.141 0.14 DBMET03344 0.145 0.135 DBMET03345 | DBMET03340 | |
| 0.279 | 0.079 | 0.449 | Spasmolytic | 0.264 0.085 DBMET03339 0.354 0.051 DBMET03340 0.256 0.089 DBMET03341 0.385 0.043 DBMET03342 0.292 0.073 DBMET03343 0.228 0.101 DBMET03344 0.323 0.061 DBMET03345 0.396 0.041 DBMET03347 0.387 0.043 DBMET03350 0.449 0.031 DBMET03352 | DBMET03352 | |
| 0.228 | 0.029 | 0.228 | 5 Hydroxytryptamine 3E antagonist | 0.185 0.092 DBMET03339 0.186 0.09 DBMET03340 0.217 0.039 DBMET03341 0.214 0.042 DBMET03342 0.186 0.09 DBMET03343 0.186 0.09 DBMET03344 0.186 0.09 DBMET03345 0.183 0.097 DBMET03346 0.183 0.097 DBMET03349 0.183 0.097 DBMET03351 | ||
| 0.214 | 0.027 | 0.221 | 5 Hydroxytryptamine 2 antagonist | 0.126 0.055 DBMET03339 0.215 0.027 DBMET03340 0.221 0.026 DBMET03342 0.109 0.066 DBMET03343 0.128 0.054 DBMET03344 0.125 0.055 DBMET03345 | DBMET03342 | |
| 0.19 | 0.004 | 0.19 | 5 Hydroxytryptamine 7 agonist | 0.081 0.012 DBMET03339 0.069 0.02 DBMET03340 0.098 0.007 DBMET03341 0.183 0.004 DBMET03342 0.138 0.005 DBMET03343 0.138 0.005 DBMET03344 0.104 0.006 DBMET03345 0.069 0.02 DBMET03346 0.069 0.02 DBMET03349 0.059 0.032 DBMET03351 | ||
| 0.199 | 0.015 | 0.199 | Alpha 1b adrenoreceptor antagonist | 0.168 0.019 DBMET03339 0.078 0.047 DBMET03341 0.19 0.015 DBMET03342 0.106 0.033 DBMET03343 0.112 0.031 DBMET03344 0.144 0.023 DBMET03345 | ||
| 0.25 | 0.068 | 0.321 | Tyrosine 3 hydroxylase inhibitor | 0.196 0.144 DBMET03339 0.194 0.148 DBMET03340 0.208 0.122 DBMET03341 0.261 0.058 DBMET03342 0.286 0.041 DBMET03343 0.286 0.041 DBMET03344 0.321 0.024 DBMET03345 | DBMET03345 | |
| 0.281 | 0.102 | 0.731 | Antithrombotic | 0.265 0.115 DBMET03339 0.297 0.09 DBMET03341 0.26 0.119 DBMET03342 0.307 0.084 DBMET03343 0.304 0.085 DBMET03344 0.309 0.083 DBMET03345 0.307 0.083 DBMET03346 0.682 0.009 DBMET03347 0.311 0.081 DBMET03349 0.686 0.009 DBMET03350 0.323 0.075 DBMET03351 0.731 0.007 DBMET03352 | DBMET03352 | |
| 0.206 | 0.028 | 0.242 | Toll-Like receptor antagonist | 0.23 0.021 DBMET03342 0.212 0.027 DBMET03343 0.242 0.018 DBMET03344 0.198 0.031 DBMET03345 | DBMET03344 | |
| 0.207 | 0.033 | 0.258 | Toll-Like receptor 9 antagonist | 0.258 0.019 DBMET03342 0.196 0.037 DBMET03343 0.16 0.057 DBMET03344 0.139 0.07 DBMET03345 | DBMET03342 | |
| 0.177 | 0.011 | 0.177 | Alpha adrenoreceptor agonist | 0.061 0.054 DBMET03339 0.118 0.022 DBMET03342 0.109 0.024 DBMET03343 0.151 0.016 DBMET03344 0.174 0.012 DBMET03345 | ||
| 0.187 | 0.024 | 0.202 | Nav1.6 sodium channel blocker | 0.176 0.031 DBMET03339 0.131 0.079 DBMET03341 0.202 0.018 DBMET03342 0.159 0.045 DBMET03343 0.137 0.071 DBMET03344 0.144 0.061 DBMET03345 | DBMET03342 | |
| 0.177 | 0.021 | 0.249 | Dopamine antagonist | 0.104 0.037 DBMET03339 0.115 0.033 DBMET03340 0.082 0.046 DBMET03341 0.249 0.015 DBMET03342 0.108 0.035 DBMET03343 0.146 0.026 DBMET03344 0.181 0.021 DBMET03345 | DBMET03342 | |
| 0.194 | 0.039 | 0.194 | Activin receptor-like kinase 2 inhibitor | 0.141 0.074 DBMET03339 0.113 0.106 DBMET03341 0.174 0.05 DBMET03342 0.167 0.055 DBMET03343 0.13 0.085 DBMET03344 0.157 0.061 DBMET03345 | ||
| 0.2 | 0.048 | 0.291 | Cytidine deaminase inhibitor | 0.199 0.048 DBMET03339 0.148 0.077 DBMET03341 0.291 0.02 DBMET03342 0.16 0.068 DBMET03343 0.188 0.053 DBMET03344 0.167 0.064 DBMET03345 | DBMET03342 | |
| 0.195 | 0.046 | 0.633 | Amylase inhibitor | 0.163 0.058 DBMET03339 0.101 0.096 DBMET03340 0.234 0.033 DBMET03341 0.137 0.071 DBMET03342 0.254 0.027 DBMET03343 0.295 0.019 DBMET03344 0.27 0.023 DBMET03345 0.492 0.006 DBMET03347 0.633 0.004 DBMET03350 0.588 0.004 DBMET03352 | DBMET03350 | |
| 0.162 | 0.02 | 0.346 | Phosphodiesterase IV inhibitor | 0.194 0.014 DBMET03339 0.346 0.005 DBMET03340 0.123 0.032 DBMET03341 0.134 0.027 DBMET03342 0.086 0.056 DBMET03343 0.101 0.044 DBMET03344 0.076 0.066 DBMET03345 | DBMET03340 | |
| 0.156 | 0.018 | 0.173 | Electron transport complex I inhibitor | 0.134 0.032 DBMET03339 0.147 0.022 DBMET03340 0.163 0.015 DBMET03341 0.173 0.012 DBMET03342 0.147 0.022 DBMET03343 0.129 0.037 DBMET03344 0.136 0.03 DBMET03345 0.095 0.094 DBMET03352 | DBMET03342 | |
| 0.143 | 0.01 | 0.143 | Alpha 1 adrenoreceptor agonist | 0.069 0.028 DBMET03339 0.051 0.049 DBMET03341 0.122 0.012 DBMET03342 0.088 0.02 DBMET03343 0.089 0.02 DBMET03344 0.114 0.014 DBMET03345 | ||
| 0.198 | 0.066 | 0.507 | Hepatoprotectant | 0.198 0.066 DBMET03339 0.15 0.109 DBMET03340 0.189 0.073 DBMET03341 0.209 0.06 DBMET03342 0.209 0.06 DBMET03343 0.227 0.051 DBMET03344 0.24 0.046 DBMET03345 0.186 0.075 DBMET03346 0.472 0.008 DBMET03347 0.193 0.07 DBMET03349 0.507 0.007 DBMET03350 0.204 0.063 DBMET03351 0.471 0.008 DBMET03352 | DBMET03350 | |
| 0.173 | 0.043 | 0.186 | Calcium channel blocker | 0.139 0.069 DBMET03339 0.186 0.036 DBMET03341 0.179 0.039 DBMET03342 0.109 0.101 DBMET03344 0.107 0.104 DBMET03345 | DBMET03341 | |
| 0.14 | 0.01 | 0.212 | Dopamine D4 agonist | 0.055 0.03 DBMET03339 0.051 0.034 DBMET03340 0.08 0.019 DBMET03341 0.212 0.006 DBMET03342 0.084 0.018 DBMET03343 0.084 0.018 DBMET03344 0.098 0.015 DBMET03345 | DBMET03342 | |
| 0.219 | 0.09 | 0.385 | Vasodilator | 0.2 0.105 DBMET03339 0.354 0.032 DBMET03340 0.162 0.14 DBMET03341 0.208 0.098 DBMET03342 0.226 0.085 DBMET03343 0.251 0.068 DBMET03344 0.257 0.065 DBMET03345 0.348 0.034 DBMET03347 0.35 0.033 DBMET03350 0.385 0.026 DBMET03352 | DBMET03352 | |
| 0.165 | 0.036 | 0.17 | Antibacterial (Helicobacter pylori) | 0.109 0.101 DBMET03339 0.135 0.061 DBMET03341 0.17 0.033 DBMET03342 0.147 0.049 DBMET03343 0.168 0.034 DBMET03344 0.166 0.035 DBMET03345 0.146 0.049 DBMET03346 0.156 0.041 DBMET03349 0.163 0.037 DBMET03351 | DBMET03342 | |
| 0.151 | 0.022 | 0.204 | Dopamine D2 antagonist | 0.088 0.036 DBMET03339 0.055 0.053 DBMET03341 0.204 0.016 DBMET03342 0.086 0.037 DBMET03343 0.127 0.026 DBMET03344 0.154 0.022 DBMET03345 | DBMET03342 | |
| 0.17 | 0.042 | 0.186 | 5 Hydroxytryptamine antagonist | 0.092 0.086 DBMET03339 0.132 0.058 DBMET03340 0.186 0.037 DBMET03342 0.093 0.086 DBMET03344 0.09 0.089 DBMET03345 | DBMET03342 | |
| 0.186 | 0.06 | 0.2 | 3C-like protease (Human coronavirus) inhibitor | 0.2 0.052 DBMET03339 0.163 0.082 DBMET03341 0.148 0.105 DBMET03342 0.15 0.101 DBMET03343 0.134 0.132 DBMET03344 | DBMET03339 | |
| 0.156 | 0.034 | 0.21 | Heat shock protein 70 antagonist | 0.142 0.069 DBMET03339 0.21 0.005 DBMET03340 0.142 0.069 DBMET03341 0.195 0.007 DBMET03342 0.165 0.022 DBMET03343 0.152 0.041 DBMET03344 0.174 0.015 DBMET03345 0.179 0.012 DBMET03347 0.164 0.023 DBMET03350 0.17 0.018 DBMET03352 | DBMET03340 | |
| 0.266 | 0.144 | 0.514 | Histamine release inhibitor | 0.263 0.146 DBMET03339 0.243 0.161 DBMET03341 0.372 0.089 DBMET03342 0.238 0.165 DBMET03343 0.261 0.147 DBMET03344 0.374 0.089 DBMET03345 0.441 0.054 DBMET03347 0.457 0.047 DBMET03350 0.514 0.024 DBMET03352 | DBMET03352 | |
| 0.144 | 0.023 | 0.144 | 5 Hydroxytryptamine agonist | 0.069 0.048 DBMET03343 0.065 0.05 DBMET03344 0.063 0.052 DBMET03345 | ||
| 0.127 | 0.009 | 0.127 | Alpha 2 adrenoreceptor agonist | 0.086 0.02 DBMET03342 0.083 0.022 DBMET03343 0.098 0.015 DBMET03344 0.123 0.009 DBMET03345 | ||
| 0.15 | 0.033 | 0.195 | Mucolytic | 0.113 0.061 DBMET03339 0.117 0.057 DBMET03340 0.195 0.015 DBMET03341 0.162 0.026 DBMET03342 0.168 0.023 DBMET03343 0.17 0.022 DBMET03344 0.171 0.022 DBMET03345 0.17 0.023 DBMET03347 0.169 0.023 DBMET03350 0.191 0.015 DBMET03352 | DBMET03341 | |
| 0.138 | 0.022 | 0.141 | 5 Hydroxytryptamine 1A antagonist | 0.125 0.024 DBMET03339 0.141 0.021 DBMET03342 0.076 0.043 DBMET03343 0.085 0.038 DBMET03344 0.089 0.036 DBMET03345 | DBMET03342 | |
| 0.133 | 0.019 | 0.234 | Dopamine D4 antagonist | 0.123 0.021 DBMET03341 0.234 0.01 DBMET03342 0.068 0.038 DBMET03343 0.086 0.03 DBMET03344 0.106 0.024 DBMET03345 | DBMET03342 | |
| 0.13 | 0.017 | 0.13 | Alpha 1d adrenoreceptor antagonist | 0.097 0.024 DBMET03339 0.066 0.037 DBMET03341 0.109 0.021 DBMET03342 0.068 0.036 DBMET03343 0.061 0.04 DBMET03344 0.069 0.035 DBMET03345 | ||
| 0.165 | 0.052 | 0.486 | Hemostatic | 0.164 0.053 DBMET03339 0.158 0.059 DBMET03341 0.163 0.054 DBMET03342 0.164 0.054 DBMET03343 0.178 0.044 DBMET03344 0.186 0.039 DBMET03345 0.267 0.019 DBMET03346 0.433 0.006 DBMET03347 0.299 0.016 DBMET03349 0.456 0.005 DBMET03350 0.405 0.007 DBMET03351 0.486 0.005 DBMET03352 | DBMET03352 | |
| 0.138 | 0.025 | 0.162 | Acetylcholine release stimulant | 0.122 0.046 DBMET03339 0.12 0.049 DBMET03340 0.132 0.032 DBMET03341 0.162 0.01 DBMET03342 0.117 0.054 DBMET03343 0.107 0.072 DBMET03344 0.104 0.079 DBMET03345 0.13 0.034 DBMET03346 0.119 0.049 DBMET03347 0.121 0.047 DBMET03349 0.11 0.067 DBMET03350 0.117 0.053 DBMET03351 0.106 0.074 DBMET03352 | DBMET03342 | |
| 0.134 | 0.023 | 0.381 | Phosphodiesterase 4D inhibitor | 0.127 0.025 DBMET03339 0.381 0.004 DBMET03340 0.12 0.028 DBMET03341 0.144 0.02 DBMET03342 0.074 0.052 DBMET03344 | DBMET03340 | |
| 0.171 | 0.064 | 0.186 | Catenin beta inhibitor | 0.15 0.106 DBMET03342 0.176 0.058 DBMET03343 0.186 0.045 DBMET03344 0.177 0.056 DBMET03345 | DBMET03344 | |
| 0.138 | 0.032 | 0.198 | Multidrug resistance-associated protein 1 inhibitor | 0.117 0.052 DBMET03339 0.101 0.076 DBMET03340 0.119 0.05 DBMET03341 0.167 0.019 DBMET03342 0.118 0.051 DBMET03343 0.128 0.04 DBMET03344 0.123 0.044 DBMET03345 0.198 0.011 DBMET03346 0.144 0.028 DBMET03347 0.175 0.016 DBMET03349 0.128 0.04 DBMET03350 0.186 0.014 DBMET03351 0.134 0.035 DBMET03352 | DBMET03346 | |
| 0.133 | 0.027 | 0.152 | 5 Hydroxytryptamine 1 antagonist | 0.112 0.033 DBMET03339 0.084 0.045 DBMET03340 0.152 0.023 DBMET03342 0.066 0.058 DBMET03343 0.076 0.049 DBMET03344 0.077 0.049 DBMET03345 | DBMET03342 | |
| 0.15 | 0.044 | 0.251 | Platelet activating factor antagonist | 0.251 0.016 DBMET03340 0.156 0.041 DBMET03341 0.204 0.025 DBMET03342 | DBMET03340 | |
| 0.201 | 0.095 | 0.225 | Potassium channel (Voltage-sensitive) blocker | 0.225 0.08 DBMET03342 | DBMET03342 | |
| 0.143 | 0.038 | 0.291 | Chelator | 0.198 0.025 DBMET03339 0.096 0.084 DBMET03341 0.145 0.037 DBMET03342 0.238 0.018 DBMET03343 0.291 0.012 DBMET03344 0.278 0.013 DBMET03345 0.11 0.064 DBMET03350 0.113 0.061 DBMET03352 | DBMET03344 | |
| 0.122 | 0.019 | 0.226 | Dopamine D1 antagonist | 0.064 0.045 DBMET03339 0.108 0.022 DBMET03340 0.226 0.009 DBMET03342 0.151 0.015 DBMET03343 0.166 0.013 DBMET03344 0.206 0.01 DBMET03345 | DBMET03342 | |
| 0.155 | 0.054 | 0.182 | Adenylate cyclase stimulant | 0.125 0.114 DBMET03341 0.126 0.111 DBMET03342 0.173 0.032 DBMET03343 0.16 0.048 DBMET03344 0.182 0.024 DBMET03345 0.17 0.035 DBMET03346 0.125 0.112 DBMET03347 0.156 0.053 DBMET03349 0.161 0.046 DBMET03351 | DBMET03345 | |
| 0.139 | 0.038 | 0.19 | Butyrylcholinesterase inhibitor | 0.128 0.043 DBMET03340 0.098 0.063 DBMET03341 0.19 0.023 DBMET03342 0.101 0.061 DBMET03343 0.104 0.059 DBMET03344 0.105 0.057 DBMET03345 | DBMET03342 | |
| 0.131 | 0.032 | 0.131 | 5 Hydroxytryptamine 2C antagonist | 0.129 0.033 DBMET03342 0.082 0.059 DBMET03344 0.074 0.067 DBMET03345 | ||
| 0.195 | 0.097 | 0.233 | Nitric-oxide synthase stimulant | 0.179 0.13 DBMET03339 0.166 0.164 DBMET03341 0.205 0.08 DBMET03343 0.233 0.046 DBMET03344 0.211 0.072 DBMET03345 0.223 0.057 DBMET03347 0.223 0.057 DBMET03350 0.205 0.08 DBMET03352 | DBMET03344 | |
| 0.159 | 0.063 | 0.352 | Lipid peroxidase inhibitor | 0.139 0.076 DBMET03341 0.157 0.063 DBMET03342 0.257 0.025 DBMET03343 0.285 0.021 DBMET03344 0.266 0.024 DBMET03345 0.352 0.013 DBMET03347 0.315 0.017 DBMET03350 0.331 0.015 DBMET03352 | DBMET03347 | |
| 0.203 | 0.107 | 0.506 | Tumour necrosis factor alpha release inhibitor | 0.17 0.134 DBMET03340 0.218 0.094 DBMET03341 0.208 0.102 DBMET03342 0.164 0.14 DBMET03343 0.221 0.092 DBMET03344 0.182 0.125 DBMET03345 0.455 0.019 DBMET03347 0.16 0.145 DBMET03349 0.447 0.02 DBMET03350 0.506 0.013 DBMET03352 | DBMET03352 | |
| 0.223 | 0.128 | 0.353 | 12-Lipoxygenase inhibitor | 0.199 0.153 DBMET03339 0.227 0.124 DBMET03342 0.328 0.066 DBMET03343 0.353 0.056 DBMET03344 0.327 0.066 DBMET03345 | DBMET03344 | |
| 0.145 | 0.053 | 0.383 | Cyclooxygenase 3 inhibitor | 0.111 0.088 DBMET03341 0.103 0.099 DBMET03342 0.151 0.048 DBMET03343 0.151 0.048 DBMET03344 0.15 0.048 DBMET03345 0.383 0.004 DBMET03347 0.383 0.004 DBMET03350 0.326 0.005 DBMET03352 | DBMET03350 | |
| 0.096 | 0.005 | 0.106 | Ryanodine receptor antagonist | 0.096 0.005 DBMET03339 0.061 0.035 DBMET03340 0.084 0.007 DBMET03341 0.085 0.006 DBMET03342 0.1 0.004 DBMET03343 0.1 0.004 DBMET03344 0.106 0.004 DBMET03345 0.063 0.03 DBMET03346 0.063 0.03 DBMET03349 0.061 0.035 DBMET03351 | DBMET03345 | |
| 0.107 | 0.016 | 0.12 | Acetylcholine M5 receptor agonist | 0.093 0.024 DBMET03339 0.08 0.034 DBMET03341 0.12 0.011 DBMET03342 0.067 0.047 DBMET03343 0.067 0.047 DBMET03344 0.064 0.051 DBMET03345 | DBMET03342 | |
| 0.096 | 0.006 | 0.173 | Calcium channel P-type blocker | 0.072 0.024 DBMET03339 0.083 0.013 DBMET03340 0.173 0.003 DBMET03341 0.102 0.005 DBMET03342 0.082 0.013 DBMET03343 0.075 0.02 DBMET03344 0.071 0.026 DBMET03345 0.063 0.045 DBMET03346 | DBMET03341 | |
| 0.222 | 0.134 | 0.361 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.194 0.164 DBMET03339 0.361 0.032 DBMET03340 0.207 0.149 DBMET03342 0.225 0.13 DBMET03343 0.254 0.103 DBMET03345 | DBMET03340 | |
| 0.124 | 0.037 | 0.133 | Breast cancer-resistant protein inhibitor | 0.101 0.054 DBMET03339 0.124 0.037 DBMET03341 0.118 0.04 DBMET03342 0.121 0.039 DBMET03343 0.097 0.058 DBMET03344 0.105 0.051 DBMET03345 0.133 0.031 DBMET03346 0.111 0.046 DBMET03349 0.1 0.055 DBMET03351 | DBMET03346 | |
| 0.096 | 0.008 | 0.096 | 5 Hydroxytryptamine 2C agonist | 0.074 0.013 DBMET03343 0.073 0.014 DBMET03344 0.07 0.015 DBMET03345 0.041 0.036 DBMET03346 | ||
| 0.112 | 0.025 | 0.127 | Histamine H2 receptor antagonist | 0.081 0.062 DBMET03339 0.127 0.018 DBMET03342 0.091 0.045 DBMET03344 0.086 0.053 DBMET03345 | DBMET03342 | |
| 0.153 | 0.066 | 0.348 | Protein kinase stimulant | 0.111 0.103 DBMET03339 0.128 0.085 DBMET03341 0.202 0.041 DBMET03342 0.155 0.065 DBMET03343 0.158 0.063 DBMET03344 0.196 0.043 DBMET03345 0.297 0.017 DBMET03347 0.303 0.016 DBMET03350 0.348 0.012 DBMET03352 | DBMET03352 | |
| 0.191 | 0.106 | 0.44 | Antiamyloidogenic | 0.153 0.144 DBMET03341 0.255 0.069 DBMET03342 0.295 0.053 DBMET03343 0.298 0.052 DBMET03344 0.271 0.062 DBMET03345 0.409 0.027 DBMET03347 0.44 0.023 DBMET03350 0.333 0.043 DBMET03352 | DBMET03350 | |
| 0.1 | 0.014 | 0.101 | 5 Hydroxytryptamine 2A agonist | 0.063 0.043 DBMET03342 0.101 0.014 DBMET03343 0.08 0.028 DBMET03344 0.083 0.025 DBMET03345 | DBMET03343 | |
| 0.109 | 0.024 | 0.109 | Nicotinic alpha4beta2 receptor antagonist | 0.095 0.035 DBMET03342 0.085 0.045 DBMET03343 0.081 0.049 DBMET03344 0.084 0.046 DBMET03345 | ||
| 0.116 | 0.032 | 0.116 | Acetylcholine nicotinic antagonist | 0.116 0.031 DBMET03342 0.096 0.042 DBMET03343 0.074 0.062 DBMET03344 0.086 0.049 DBMET03345 | ||
| 0.107 | 0.024 | 0.122 | 5 Hydroxytryptamine 7 antagonist | 0.122 0.021 DBMET03340 0.094 0.026 DBMET03342 0.064 0.042 DBMET03344 0.056 0.049 DBMET03345 | DBMET03340 | |
| 0.154 | 0.071 | 0.208 | Acetylcholine M1 receptor antagonist | 0.116 0.114 DBMET03341 0.208 0.039 DBMET03342 0.158 0.067 DBMET03343 0.163 0.063 DBMET03344 0.171 0.058 DBMET03345 | DBMET03342 | |
| 0.14 | 0.059 | 0.167 | Cholinergic antagonist | 0.157 0.049 DBMET03340 0.167 0.044 DBMET03342 0.138 0.059 DBMET03343 0.127 0.067 DBMET03344 0.136 0.061 DBMET03345 | DBMET03342 | |
| 0.119 | 0.038 | 0.144 | 5 Hydroxytryptamine 2A antagonist | 0.076 0.062 DBMET03339 0.144 0.03 DBMET03340 0.127 0.035 DBMET03342 | DBMET03340 | |
| 0.097 | 0.017 | 0.106 | 5 Hydroxytryptamine 3 agonist | 0.106 0.013 DBMET03342 0.081 0.026 DBMET03343 0.081 0.026 DBMET03344 0.081 0.026 DBMET03345 | DBMET03342 | |
| 0.111 | 0.033 | 0.171 | Phosphodiesterase I inhibitor | 0.129 0.023 DBMET03339 0.091 0.057 DBMET03341 0.171 0.014 DBMET03342 0.128 0.024 DBMET03343 0.101 0.043 DBMET03344 0.095 0.051 DBMET03345 | DBMET03342 | |
| 0.241 | 0.162 | 0.293 | GABA C receptor rho-3 antagonist | 0.293 0.121 DBMET03342 0.249 0.155 DBMET03343 0.249 0.155 DBMET03344 0.249 0.155 DBMET03345 | DBMET03342 | |
| 0.136 | 0.058 | 0.163 | Acetylcholine antagonist | 0.154 0.048 DBMET03340 0.163 0.044 DBMET03342 0.132 0.061 DBMET03343 0.124 0.067 DBMET03344 0.133 0.06 DBMET03345 | DBMET03342 | |
| 0.124 | 0.048 | 0.484 | Expectorant | 0.092 0.079 DBMET03340 0.175 0.027 DBMET03341 0.162 0.031 DBMET03342 0.15 0.035 DBMET03343 0.151 0.035 DBMET03344 0.157 0.033 DBMET03345 0.422 0.005 DBMET03347 0.413 0.005 DBMET03350 0.484 0.004 DBMET03352 | DBMET03352 | |
| 0.175 | 0.1 | 0.184 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.181 0.094 DBMET03342 0.184 0.09 DBMET03343 0.159 0.12 DBMET03345 | DBMET03343 | |
| 0.136 | 0.063 | 0.204 | Toll-Like receptor 2 antagonist | 0.109 0.091 DBMET03342 0.204 0.022 DBMET03343 0.18 0.034 DBMET03344 0.179 0.034 DBMET03345 | DBMET03343 | |
| 0.129 | 0.056 | 0.479 | Monophenol monooxygenase inhibitor | 0.121 0.061 DBMET03341 0.1 0.076 DBMET03342 0.268 0.022 DBMET03343 0.243 0.025 DBMET03344 0.219 0.029 DBMET03345 0.479 0.008 DBMET03347 0.438 0.01 DBMET03350 0.467 0.009 DBMET03352 | DBMET03347 | |
| 0.096 | 0.027 | 0.126 | CC chemokine 5 receptor agonist | 0.082 0.059 DBMET03339 0.085 0.049 DBMET03340 0.082 0.058 DBMET03341 0.095 0.029 DBMET03342 0.101 0.021 DBMET03343 0.101 0.021 DBMET03344 0.101 0.021 DBMET03345 0.126 0.006 DBMET03346 0.126 0.006 DBMET03349 0.126 0.006 DBMET03351 | DBMET03351 | |
| 0.075 | 0.006 | 0.103 | Dopamine beta hydroxylase inhibitor | 0.051 0.029 DBMET03339 0.045 0.044 DBMET03340 0.077 0.005 DBMET03342 0.082 0.005 DBMET03343 0.103 0.004 DBMET03344 0.101 0.004 DBMET03345 | DBMET03344 | |
| 0.22 | 0.151 | 0.673 | Transcription factor NF kappa B inhibitor | 0.245 0.131 DBMET03339 0.203 0.165 DBMET03341 0.241 0.134 DBMET03342 0.273 0.111 DBMET03343 0.29 0.1 DBMET03344 0.292 0.099 DBMET03345 0.673 0.024 DBMET03347 0.665 0.025 DBMET03350 0.648 0.026 DBMET03352 | DBMET03347 | |
| 0.152 | 0.084 | 0.316 | Sigma receptor agonist | 0.245 0.05 DBMET03341 0.316 0.036 DBMET03342 0.146 0.088 DBMET03343 0.146 0.088 DBMET03344 0.122 0.111 DBMET03345 | DBMET03342 | |
| 0.146 | 0.079 | 0.149 | GABA C receptor rho-2 antagonist | 0.145 0.081 DBMET03339 0.149 0.075 DBMET03342 0.142 0.085 DBMET03343 0.142 0.085 DBMET03344 0.127 0.111 DBMET03345 | DBMET03342 | |
| 0.181 | 0.114 | 0.593 | Free radical scavenger | 0.179 0.116 DBMET03341 0.183 0.111 DBMET03342 0.331 0.044 DBMET03343 0.399 0.029 DBMET03344 0.372 0.034 DBMET03345 0.571 0.01 DBMET03347 0.593 0.009 DBMET03350 0.544 0.012 DBMET03352 | DBMET03350 | |
| 0.101 | 0.034 | 0.134 | Myeloperoxidase inhibitor | 0.092 0.046 DBMET03342 0.096 0.04 DBMET03343 0.134 0.015 DBMET03344 0.114 0.023 DBMET03345 | DBMET03344 | |
| 0.155 | 0.089 | 0.168 | Neurotensin receptor agonist | 0.149 0.103 DBMET03341 0.14 0.129 DBMET03342 0.151 0.099 DBMET03343 0.168 0.066 DBMET03344 0.154 0.092 DBMET03345 | DBMET03344 | |
| 0.127 | 0.061 | 0.174 | Acetylcholine muscarinic antagonist | 0.174 0.032 DBMET03340 0.102 0.089 DBMET03341 0.162 0.037 DBMET03342 0.127 0.06 DBMET03343 0.13 0.058 DBMET03344 0.134 0.055 DBMET03345 | DBMET03340 | |
| 0.19 | 0.124 | 0.225 | DNA damaging | 0.2 0.115 DBMET03342 0.211 0.107 DBMET03343 0.223 0.098 DBMET03344 0.198 0.117 DBMET03345 0.225 0.097 DBMET03347 0.207 0.11 DBMET03350 0.199 0.116 DBMET03352 | DBMET03347 | |
| 0.252 | 0.187 | 0.267 | MAP kinase kinase 6 inhibitor | 0.267 0.169 DBMET03339 0.237 0.208 DBMET03343 0.237 0.208 DBMET03344 | DBMET03339 | |
| 0.09 | 0.025 | 0.129 | Beta tubulin antagonist | 0.054 0.044 DBMET03339 0.129 0.015 DBMET03340 0.074 0.032 DBMET03341 0.102 0.021 DBMET03342 0.1 0.022 DBMET03343 0.079 0.03 DBMET03344 0.113 0.019 DBMET03345 | DBMET03340 | |
| 0.091 | 0.027 | 0.125 | Phosphodiesterase VI inhibitor | 0.091 0.027 DBMET03339 0.087 0.031 DBMET03341 0.125 0.011 DBMET03342 0.086 0.032 DBMET03343 0.082 0.037 DBMET03344 0.089 0.03 DBMET03345 0.099 0.021 DBMET03347 0.084 0.035 DBMET03350 0.101 0.019 DBMET03352 | DBMET03342 | |
| 0.111 | 0.048 | 0.144 | Protein kinase C mu inhibitor | 0.137 0.032 DBMET03339 0.101 0.056 DBMET03343 0.144 0.029 DBMET03344 0.12 0.042 DBMET03345 | DBMET03344 | |
| 0.122 | 0.06 | 0.173 | Calcium channel N-type blocker | 0.173 0.025 DBMET03341 0.148 0.039 DBMET03342 | DBMET03341 | |
| 0.166 | 0.104 | 0.353 | DNA methylase inhibitor | 0.218 0.068 DBMET03342 0.248 0.049 DBMET03343 0.252 0.047 DBMET03344 0.196 0.081 DBMET03345 0.347 0.017 DBMET03347 0.347 0.017 DBMET03350 0.353 0.016 DBMET03352 | DBMET03352 | |
| 0.094 | 0.033 | 0.117 | Acetylcholine M4 receptor antagonist | 0.117 0.019 DBMET03342 | DBMET03342 | |
| 0.09 | 0.029 | 0.09 | Toll-Like receptor 7 antagonist | 0.071 0.046 DBMET03342 | ||
| 0.118 | 0.057 | 0.118 | 5 Hydroxytryptamine 3A agonist | 0.108 0.067 DBMET03342 0.096 0.08 DBMET03343 0.096 0.08 DBMET03344 0.096 0.08 DBMET03345 | ||
| 0.091 | 0.031 | 0.154 | Dopamine agonist | 0.105 0.025 DBMET03342 0.104 0.026 DBMET03343 0.096 0.029 DBMET03344 0.154 0.015 DBMET03345 0.061 0.051 DBMET03346 0.069 0.044 DBMET03349 0.085 0.034 DBMET03351 | DBMET03345 | |
| 0.089 | 0.03 | 0.089 | Neuronal nicotinic receptor antagonist | 0.086 0.031 DBMET03342 0.076 0.039 DBMET03343 0.065 0.049 DBMET03344 0.071 0.044 DBMET03345 | ||
| 0.17 | 0.11 | 0.192 | HERG channel blocker | 0.192 0.095 DBMET03342 | DBMET03342 | |
| 0.163 | 0.105 | 0.2 | Psychostimulant | 0.171 0.099 DBMET03339 0.161 0.107 DBMET03342 0.162 0.106 DBMET03343 0.134 0.132 DBMET03344 0.171 0.099 DBMET03345 0.2 0.08 DBMET03347 0.168 0.101 DBMET03350 0.175 0.096 DBMET03352 | DBMET03347 | |
| 0.113 | 0.055 | 0.126 | GABA C receptor agonist | 0.126 0.045 DBMET03343 0.126 0.045 DBMET03344 0.126 0.045 DBMET03345 | DBMET03345 | |
| 0.115 | 0.057 | 0.188 | Falcipain 3 inhibitor | 0.112 0.06 DBMET03341 0.188 0.021 DBMET03342 0.141 0.041 DBMET03343 0.104 0.066 DBMET03344 0.132 0.046 DBMET03345 | DBMET03342 | |
| 0.269 | 0.213 | 0.378 | MAP kinase 1 inhibitor | 0.378 0.12 DBMET03341 0.341 0.142 DBMET03342 | DBMET03341 | |
| 0.106 | 0.049 | 0.106 | Glutamate (mGluR7) agonist | 0.092 0.078 DBMET03339 0.105 0.05 DBMET03341 0.099 0.062 DBMET03342 | ||
| 0.123 | 0.067 | 0.226 | DNA repair enzyme inhibitor | 0.136 0.047 DBMET03342 0.127 0.06 DBMET03343 0.148 0.034 DBMET03344 0.128 0.058 DBMET03345 0.226 0.006 DBMET03347 0.226 0.006 DBMET03350 0.209 0.008 DBMET03352 | DBMET03350 | |
| 0.184 | 0.128 | 0.615 | Antioxidant | 0.177 0.135 DBMET03341 0.194 0.118 DBMET03342 0.328 0.053 DBMET03343 0.359 0.044 DBMET03344 0.349 0.047 DBMET03345 0.244 0.087 DBMET03346 0.614 0.01 DBMET03347 0.244 0.087 DBMET03349 0.615 0.01 DBMET03350 0.29 0.065 DBMET03351 0.596 0.012 DBMET03352 | DBMET03350 | |
| 0.063 | 0.008 | 0.063 | 5 Hydroxytryptamine 2B agonist | 0.044 0.019 DBMET03343 0.039 0.027 DBMET03344 0.041 0.024 DBMET03345 | ||
| 0.093 | 0.038 | 0.104 | Caspase 7 inhibitor | 0.104 0.025 DBMET03342 0.081 0.058 DBMET03343 0.08 0.061 DBMET03344 0.085 0.05 DBMET03345 | DBMET03342 | |
| 0.077 | 0.022 | 0.115 | Heat shock protein 90 beta antagonist | 0.054 0.051 DBMET03339 0.085 0.017 DBMET03342 0.092 0.014 DBMET03343 0.091 0.014 DBMET03344 0.115 0.008 DBMET03345 | DBMET03345 | |
| 0.06 | 0.005 | 0.07 | Motilin receptor agonist | 0.023 0.015 DBMET03339 0.023 0.016 DBMET03341 0.038 0.007 DBMET03343 0.038 0.007 DBMET03344 0.038 0.007 DBMET03345 0.024 0.014 DBMET03346 0.07 0.005 DBMET03347 0.024 0.014 DBMET03349 0.07 0.005 DBMET03350 0.024 0.014 DBMET03351 0.07 0.005 DBMET03352 | DBMET03352 | |
| 0.088 | 0.034 | 0.116 | Phosphodiesterase V inhibitor | 0.116 0.02 DBMET03339 0.064 0.059 DBMET03340 0.069 0.052 DBMET03341 0.111 0.023 DBMET03342 0.065 0.057 DBMET03345 | DBMET03339 | |
| 0.156 | 0.102 | 0.201 | Succinate dehydrogenase inhibitor | 0.144 0.125 DBMET03340 0.156 0.101 DBMET03341 0.15 0.113 DBMET03342 0.201 0.048 DBMET03343 0.175 0.073 DBMET03344 0.179 0.068 DBMET03345 | DBMET03343 | |
| 0.082 | 0.029 | 0.088 | 5 Hydroxytryptamine 3A antagonist | 0.088 0.024 DBMET03342 | DBMET03342 | |
| 0.087 | 0.034 | 0.117 | Phosphodiesterase 5A inhibitor | 0.117 0.02 DBMET03339 0.064 0.057 DBMET03340 0.069 0.051 DBMET03341 0.111 0.022 DBMET03342 0.064 0.057 DBMET03345 | DBMET03339 | |
| 0.112 | 0.06 | 0.126 | Protein kinase C gamma inhibitor | 0.102 0.074 DBMET03339 0.118 0.054 DBMET03342 0.118 0.054 DBMET03343 0.124 0.049 DBMET03344 0.126 0.048 DBMET03345 | DBMET03345 | |
| 0.075 | 0.025 | 0.075 | Calcium channel T-type blocker | 0.066 0.031 DBMET03339 0.07 0.028 DBMET03341 0.073 0.026 DBMET03342 | ||
| 0.059 | 0.009 | 0.059 | Alpha 1L adrenoreceptor agonist | 0.047 0.02 DBMET03339 0.049 0.017 DBMET03343 0.049 0.017 DBMET03344 0.049 0.017 DBMET03345 0.047 0.02 DBMET03346 0.047 0.02 DBMET03349 0.047 0.02 DBMET03351 | ||
| 0.094 | 0.044 | 0.101 | Granulocyte macrophage colony stimulating factor agonist | 0.085 0.063 DBMET03341 0.081 0.072 DBMET03342 0.096 0.04 DBMET03343 0.096 0.04 DBMET03344 0.101 0.034 DBMET03345 | DBMET03345 | |
| 0.075 | 0.026 | 0.112 | Phosphodiesterase 1B inhibitor | 0.075 0.026 DBMET03339 0.067 0.033 DBMET03341 0.112 0.012 DBMET03342 0.078 0.024 DBMET03343 0.064 0.037 DBMET03344 0.055 0.05 DBMET03345 | DBMET03342 | |
| 0.065 | 0.017 | 0.065 | Alpha 1L adrenoreceptor antagonist | 0.06 0.022 DBMET03339 0.052 0.037 DBMET03340 0.054 0.031 DBMET03341 0.059 0.023 DBMET03342 0.058 0.025 DBMET03343 0.058 0.025 DBMET03344 0.058 0.025 DBMET03345 | ||
| 0.073 | 0.026 | 0.083 | Phosphodiesterase 1C inhibitor | 0.083 0.017 DBMET03342 0.07 0.029 DBMET03343 0.07 0.03 DBMET03344 0.064 0.038 DBMET03345 | DBMET03342 | |
| 0.106 | 0.061 | 0.378 | Beta glucuronidase inhibitor | 0.157 0.022 DBMET03343 0.125 0.041 DBMET03344 0.14 0.03 DBMET03345 0.376 0.004 DBMET03347 0.353 0.005 DBMET03350 0.378 0.004 DBMET03352 | DBMET03352 | |
| 0.078 | 0.033 | 0.118 | Dopamine D3 antagonist | 0.079 0.033 DBMET03340 0.118 0.02 DBMET03342 0.058 0.047 DBMET03344 0.065 0.041 DBMET03345 | DBMET03342 | |
| 0.069 | 0.024 | 0.084 | Sigma receptor antagonist | 0.053 0.033 DBMET03340 0.084 0.019 DBMET03342 0.05 0.035 DBMET03344 0.049 0.035 DBMET03345 | DBMET03342 | |
| 0.091 | 0.047 | 0.091 | ALK inhibitor | 0.086 0.052 DBMET03342 0.081 0.058 DBMET03343 | ||
| 0.119 | 0.075 | 0.153 | Nav1.3 sodium channel blocker | 0.108 0.088 DBMET03339 0.153 0.045 DBMET03342 | DBMET03342 | |
| 0.098 | 0.055 | 0.155 | Phosphodiesterase 6D inhibitor | 0.099 0.053 DBMET03339 0.123 0.022 DBMET03342 0.1 0.052 DBMET03343 0.106 0.042 DBMET03344 0.107 0.04 DBMET03345 0.145 0.011 DBMET03347 0.135 0.015 DBMET03350 0.155 0.009 DBMET03352 | DBMET03352 | |
| 0.147 | 0.104 | 0.16 | Cyclin-dependent kinase 3 inhibitor | 0.157 0.08 DBMET03339 0.16 0.077 DBMET03342 0.147 0.103 DBMET03343 0.147 0.103 DBMET03344 0.147 0.103 DBMET03345 | DBMET03342 | |
| 0.163 | 0.12 | 0.219 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.219 0.059 DBMET03342 0.188 0.083 DBMET03343 0.206 0.067 DBMET03344 0.197 0.075 DBMET03345 0.15 0.149 DBMET03352 | DBMET03342 | |
| 0.196 | 0.155 | 0.272 | Gastrin inhibitor | 0.265 0.063 DBMET03341 0.272 0.055 DBMET03342 | DBMET03342 | |
| 0.071 | 0.03 | 0.071 | 5 Hydroxytryptamine 5A antagonist | 0.07 0.031 DBMET03342 0.059 0.046 DBMET03344 0.062 0.042 DBMET03345 | ||
| 0.071 | 0.03 | 0.071 | Cyclin-dependent kinase 6 inhibitor | 0.053 0.05 DBMET03339 0.061 0.04 DBMET03342 0.059 0.042 DBMET03343 0.057 0.045 DBMET03344 0.065 0.036 DBMET03345 | ||
| 0.066 | 0.026 | 0.107 | Alpha tubulin antagonist | 0.107 0.014 DBMET03340 0.047 0.045 DBMET03341 0.063 0.028 DBMET03342 0.089 0.017 DBMET03343 0.067 0.026 DBMET03344 0.09 0.017 DBMET03345 | DBMET03340 | |
| 0.064 | 0.024 | 0.064 | Chemokine receptor agonist | 0.055 0.032 DBMET03339 0.047 0.037 DBMET03341 | ||
| 0.11 | 0.071 | 0.111 | Interleukin 1b antagonist | 0.097 0.085 DBMET03339 0.105 0.075 DBMET03341 0.111 0.07 DBMET03342 | DBMET03342 | |
| 0.185 | 0.146 | 0.374 | DNA synthesis inhibitor | 0.173 0.163 DBMET03342 0.208 0.111 DBMET03343 0.197 0.128 DBMET03344 0.206 0.115 DBMET03345 0.352 0.03 DBMET03347 0.363 0.028 DBMET03350 0.374 0.025 DBMET03352 | DBMET03352 | |
| 0.151 | 0.113 | 0.237 | Anesthetic general | 0.158 0.106 DBMET03341 0.237 0.056 DBMET03342 0.186 0.083 DBMET03343 0.146 0.118 DBMET03344 0.174 0.091 DBMET03345 0.184 0.084 DBMET03347 0.145 0.12 DBMET03350 0.199 0.075 DBMET03352 | DBMET03342 | |
| 0.095 | 0.057 | 0.095 | Alpha 2d adrenoreceptor antagonist | |||
| 0.08 | 0.042 | 0.096 | GABA B receptor agonist | 0.091 0.024 DBMET03343 0.091 0.024 DBMET03344 0.096 0.019 DBMET03345 | DBMET03345 | |
| 0.12 | 0.083 | 0.161 | Nav1.2 sodium channel blocker | 0.161 0.051 DBMET03339 0.123 0.08 DBMET03342 | DBMET03339 | |
| 0.108 | 0.071 | 0.108 | Activin receptor-like kinase 4 inhibitor | |||
| 0.108 | 0.072 | 0.119 | Nav1.5 sodium channel blocker | 0.095 0.094 DBMET03339 0.119 0.055 DBMET03342 | DBMET03342 | |
| 0.079 | 0.043 | 0.105 | 5 Hydroxytryptamine 1F antagonist | 0.105 0.029 DBMET03342 | DBMET03342 | |
| 0.066 | 0.03 | 0.066 | 5 Hydroxytryptamine 5 antagonist | 0.066 0.03 DBMET03342 0.054 0.047 DBMET03344 0.056 0.043 DBMET03345 | ||
| 0.056 | 0.02 | 0.066 | Potassium channel small-conductance Ca-activated blocker | 0.066 0.014 DBMET03342 | DBMET03342 | |
| 0.056 | 0.021 | 0.056 | Carnitine palmitoyltransferase 1B inhibitor | 0.043 0.042 DBMET03339 0.043 0.042 DBMET03340 0.044 0.04 DBMET03341 0.052 0.026 DBMET03342 0.045 0.038 DBMET03343 0.049 0.03 DBMET03344 0.051 0.028 DBMET03345 | ||
| 0.045 | 0.01 | 0.047 | Carnitine palmitoyltransferase 1 inhibitor | 0.038 0.017 DBMET03339 0.037 0.019 DBMET03341 0.047 0.009 DBMET03342 0.034 0.024 DBMET03344 0.037 0.02 DBMET03345 | DBMET03342 | |
| 0.083 | 0.048 | 0.161 | Macrophage migration inhibitory factor inhibitor | 0.08 0.052 DBMET03340 0.077 0.055 DBMET03341 0.099 0.035 DBMET03342 0.093 0.039 DBMET03343 0.161 0.012 DBMET03344 0.148 0.016 DBMET03345 | DBMET03344 | |
| 0.045 | 0.011 | 0.047 | Carnitine palmitoyltransferase inhibitor | 0.038 0.019 DBMET03339 0.036 0.02 DBMET03341 0.047 0.01 DBMET03342 0.033 0.025 DBMET03344 0.036 0.021 DBMET03345 | DBMET03342 | |
| 0.071 | 0.038 | 0.071 | 5 Hydroxytryptamine uptake inhibitor | 0.055 0.051 DBMET03342 | ||
| 0.076 | 0.043 | 0.076 | Calcium channel L-type blocker | 0.075 0.046 DBMET03341 0.073 0.047 DBMET03342 | ||
| 0.066 | 0.033 | 0.098 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.063 0.037 DBMET03339 0.074 0.024 DBMET03342 0.067 0.032 DBMET03343 0.083 0.017 DBMET03344 0.098 0.011 DBMET03345 | DBMET03345 | |
| 0.059 | 0.027 | 0.059 | 5 Hydroxytryptamine 2 agonist | 0.046 0.042 DBMET03343 | ||
| 0.036 | 0.005 | 0.036 | Glutaminyl-peptide cyclotransferase inhibitor | 0.02 0.018 DBMET03341 0.023 0.013 DBMET03342 0.02 0.019 DBMET03344 | ||
| 0.066 | 0.034 | 0.066 | Cyclin D1 inhibitor | 0.065 0.036 DBMET03342 0.061 0.04 DBMET03343 0.063 0.038 DBMET03345 | ||
| 0.106 | 0.075 | 0.126 | Calcium channel (voltage-sensitive) blocker | 0.126 0.05 DBMET03341 0.117 0.061 DBMET03342 | DBMET03341 | |
| 0.092 | 0.061 | 0.115 | Protein kinase C zeta inhibitor | 0.096 0.056 DBMET03342 0.103 0.047 DBMET03343 0.114 0.037 DBMET03344 0.108 0.041 DBMET03345 0.115 0.036 DBMET03346 0.101 0.05 DBMET03349 0.1 0.051 DBMET03351 | DBMET03346 | |
| 0.048 | 0.018 | 0.057 | Acid-sensing ion channel blocker | 0.057 0.011 DBMET03342 0.044 0.023 DBMET03343 0.044 0.023 DBMET03344 0.047 0.019 DBMET03345 | DBMET03342 | |
| 0.079 | 0.049 | 0.09 | MAP kinase kinase 7 inhibitor | 0.09 0.024 DBMET03340 0.09 0.025 DBMET03343 0.09 0.025 DBMET03344 0.088 0.028 DBMET03345 | DBMET03344 | |
| 0.118 | 0.088 | 0.154 | Bone formation stimulant | 0.104 0.102 DBMET03339 0.13 0.077 DBMET03343 0.154 0.056 DBMET03344 0.138 0.069 DBMET03345 0.104 0.102 DBMET03347 0.117 0.088 DBMET03350 0.116 0.089 DBMET03352 | DBMET03344 | |
| 0.142 | 0.113 | 0.312 | DNA methyltransferase I inhibitor | 0.191 0.074 DBMET03342 0.234 0.054 DBMET03343 0.24 0.051 DBMET03344 0.169 0.087 DBMET03345 0.308 0.023 DBMET03347 0.308 0.023 DBMET03350 0.312 0.022 DBMET03352 | DBMET03352 | |
| 0.071 | 0.043 | 0.102 | Potassium channel large-conductance Ca-activated activator | 0.063 0.053 DBMET03339 0.084 0.032 DBMET03342 0.102 0.023 DBMET03343 0.102 0.023 DBMET03344 0.102 0.023 DBMET03345 | DBMET03345 | |
| 0.096 | 0.068 | 0.096 | GABA C receptor rho-1 antagonist | 0.094 0.071 DBMET03343 0.094 0.071 DBMET03344 | ||
| 0.133 | 0.106 | 0.153 | Ca2+-transporting ATPase inhibitor | 0.131 0.117 DBMET03341 0.153 0.036 DBMET03342 0.14 0.075 DBMET03343 0.14 0.075 DBMET03344 0.14 0.075 DBMET03345 0.135 0.095 DBMET03347 0.135 0.095 DBMET03350 0.135 0.095 DBMET03352 | DBMET03342 | |
| 0.055 | 0.029 | 0.07 | 5 Hydroxytryptamine 4 antagonist | 0.047 0.044 DBMET03341 0.07 0.017 DBMET03342 0.049 0.041 DBMET03345 | DBMET03342 | |
| 0.062 | 0.036 | 0.083 | Phosphodiesterase 1A inhibitor | 0.075 0.019 DBMET03339 0.083 0.015 DBMET03342 0.059 0.043 DBMET03343 | DBMET03342 | |
| 0.078 | 0.053 | 0.116 | Viral attachment inhibitor | 0.072 0.07 DBMET03339 0.101 0.023 DBMET03340 0.116 0.016 DBMET03341 0.077 0.056 DBMET03344 0.072 0.07 DBMET03345 0.085 0.04 DBMET03346 0.081 0.048 DBMET03349 0.082 0.045 DBMET03351 | DBMET03341 | |
| 0.053 | 0.028 | 0.053 | Alpha 1b adrenoreceptor agonist | 0.051 0.034 DBMET03343 0.051 0.034 DBMET03344 0.05 0.036 DBMET03345 | ||
| 0.067 | 0.042 | 0.077 | 5 Hydroxytryptamine 1D antagonist | 0.066 0.043 DBMET03340 0.077 0.033 DBMET03342 | DBMET03342 | |
| 0.081 | 0.056 | 0.128 | Adrenaline agonist | 0.097 0.039 DBMET03343 0.115 0.028 DBMET03344 0.128 0.022 DBMET03345 | DBMET03345 | |
| 0.172 | 0.148 | 0.22 | RNA-directed DNA polymerase inhibitor | 0.175 0.142 DBMET03339 0.187 0.121 DBMET03342 0.22 0.074 DBMET03343 0.209 0.087 DBMET03344 0.21 0.086 DBMET03345 0.169 0.154 DBMET03346 0.171 0.149 DBMET03347 | DBMET03343 | |
| 0.069 | 0.045 | 0.073 | Exportin-1 inhibitor | 0.073 0.038 DBMET03341 | DBMET03341 | |
| 0.045 | 0.021 | 0.07 | Dopamine D5 agonist | 0.065 0.01 DBMET03343 0.065 0.01 DBMET03344 0.07 0.008 DBMET03345 | DBMET03345 | |
| 0.067 | 0.043 | 0.077 | 5 Hydroxytryptamine 1B antagonist | 0.077 0.036 DBMET03342 | DBMET03342 | |
| 0.052 | 0.028 | 0.052 | CC chemokine receptor 2B antagonist | 0.047 0.039 DBMET03343 0.047 0.039 DBMET03344 0.045 0.043 DBMET03345 | ||
| 0.082 | 0.059 | 0.085 | Inducible nitric-oxide synthase inhibitor | 0.085 0.055 DBMET03340 0.075 0.071 DBMET03344 0.075 0.071 DBMET03345 | DBMET03340 | |
| 0.106 | 0.084 | 0.106 | Sphingosine 1-phosphate receptor 2 agonist | 0.101 0.099 DBMET03343 0.101 0.099 DBMET03344 | ||
| 0.058 | 0.038 | 0.058 | 5 Hydroxytryptamine 6 antagonist | 0.058 0.038 DBMET03342 | ||
| 0.06 | 0.041 | 0.083 | Acetylcholine M3 receptor antagonist | 0.083 0.025 DBMET03340 0.068 0.033 DBMET03342 0.069 0.032 DBMET03343 0.067 0.033 DBMET03344 0.066 0.035 DBMET03345 | DBMET03340 | |
| 0.034 | 0.015 | 0.066 | Sigma 2 receptor antagonist | 0.066 0.007 DBMET03340 0.043 0.012 DBMET03341 0.051 0.01 DBMET03342 0.027 0.019 DBMET03344 0.023 0.022 DBMET03345 | DBMET03340 | |
| 0.029 | 0.01 | 0.036 | Urotensin II antagonist | 0.036 0.008 DBMET03342 | DBMET03342 | |
| 0.033 | 0.015 | 0.042 | Sigma 1 receptor antagonist | 0.023 0.021 DBMET03341 0.042 0.012 DBMET03342 | DBMET03342 | |
| 0.142 | 0.124 | 0.186 | Phospholipase C inhibitor | 0.186 0.055 DBMET03343 0.163 0.082 DBMET03344 0.179 0.062 DBMET03345 0.144 0.119 DBMET03346 0.139 0.132 DBMET03347 0.144 0.119 DBMET03349 0.139 0.132 DBMET03350 0.142 0.124 DBMET03351 | DBMET03343 | |
| 0.11 | 0.093 | 0.26 | Phosphodiesterase inhibitor | 0.16 0.052 DBMET03339 0.26 0.02 DBMET03340 0.103 0.102 DBMET03341 0.126 0.076 DBMET03342 | DBMET03340 | |
| 0.124 | 0.107 | 0.299 | Heat shock protein 90 antagonist | 0.125 0.106 DBMET03339 0.299 0.01 DBMET03340 0.146 0.079 DBMET03341 0.153 0.072 DBMET03342 0.199 0.039 DBMET03343 0.15 0.075 DBMET03344 0.177 0.051 DBMET03345 | DBMET03340 | |
| 0.056 | 0.039 | 0.063 | Phosphodiesterase 4C inhibitor | 0.063 0.032 DBMET03339 0.057 0.037 DBMET03342 | DBMET03339 | |
| 0.037 | 0.021 | 0.037 | CXC chemokine receptor agonist | 0.031 0.026 DBMET03339 | ||
| 0.214 | 0.198 | 0.365 | 15-Lipoxygenase inhibitor | 0.263 0.154 DBMET03341 0.282 0.142 DBMET03342 0.35 0.099 DBMET03343 0.365 0.091 DBMET03344 0.344 0.103 DBMET03345 | DBMET03344 | |
| 0.081 | 0.066 | 0.092 | mTOR complex 2 inhibitor | 0.085 0.058 DBMET03341 0.085 0.057 DBMET03342 0.092 0.044 DBMET03343 0.079 0.071 DBMET03344 0.081 0.065 DBMET03345 | DBMET03343 | |
| 0.132 | 0.117 | 0.42 | Nitric oxide antagonist | 0.134 0.114 DBMET03341 0.141 0.104 DBMET03342 0.161 0.087 DBMET03343 0.184 0.074 DBMET03344 0.188 0.072 DBMET03345 0.132 0.116 DBMET03346 0.404 0.025 DBMET03347 0.136 0.11 DBMET03349 0.42 0.023 DBMET03350 0.163 0.085 DBMET03351 0.399 0.026 DBMET03352 | DBMET03350 | |
| 0.081 | 0.066 | 0.11 | Insulin growth factor antagonist | 0.11 0.04 DBMET03340 0.088 0.057 DBMET03341 0.088 0.056 DBMET03342 0.085 0.06 DBMET03343 | DBMET03340 | |
| 0.076 | 0.062 | 0.167 | Histamine H1 receptor antagonist | 0.167 0.02 DBMET03340 0.09 0.048 DBMET03341 0.128 0.03 DBMET03342 | DBMET03340 | |
| 0.042 | 0.029 | 0.042 | CC chemokine 3 receptor antagonist | 0.036 0.034 DBMET03341 | ||
| 0.077 | 0.065 | 0.103 | Insulin like growth factor 1 antagonist | 0.103 0.04 DBMET03340 0.084 0.056 DBMET03341 0.084 0.055 DBMET03342 0.078 0.064 DBMET03343 | DBMET03340 | |
| 0.101 | 0.089 | 0.15 | Microtubule formation inhibitor | 0.116 0.065 DBMET03339 0.15 0.037 DBMET03340 0.098 0.094 DBMET03341 0.112 0.071 DBMET03342 0.098 0.095 DBMET03343 0.105 0.082 DBMET03345 0.127 0.054 DBMET03347 0.122 0.058 DBMET03350 0.127 0.053 DBMET03352 | DBMET03340 | |
| 0.025 | 0.013 | 0.029 | CC chemokine 8 receptor antagonist | 0.029 0.006 DBMET03341 0.024 0.014 DBMET03342 | DBMET03341 | |
| 0.065 | 0.054 | 0.074 | ZAP-70 protein tyrosine kinase inhibitor | 0.062 0.058 DBMET03341 0.074 0.043 DBMET03342 | DBMET03342 | |
| 0.076 | 0.064 | 0.132 | Glycine receptor antagonist | 0.08 0.056 DBMET03343 0.074 0.068 DBMET03344 0.074 0.067 DBMET03345 0.078 0.06 DBMET03346 0.124 0.016 DBMET03347 0.117 0.02 DBMET03350 0.072 0.071 DBMET03351 0.132 0.013 DBMET03352 | DBMET03352 | |
| 0.046 | 0.035 | 0.046 | CC chemokine 4 receptor antagonist | 0.045 0.035 DBMET03342 | ||
| 0.044 | 0.033 | 0.059 | 5 Hydroxytryptamine 1A agonist | 0.059 0.025 DBMET03340 | DBMET03340 | |
| 0.128 | 0.118 | 0.259 | Melanin inhibitor | 0.173 0.057 DBMET03343 0.163 0.065 DBMET03344 0.164 0.065 DBMET03345 0.259 0.027 DBMET03347 0.227 0.033 DBMET03350 0.227 0.033 DBMET03352 | DBMET03347 | |
| 0.029 | 0.019 | 0.034 | Estrogen-related receptor gamma antagonist | 0.034 0.01 DBMET03342 0.034 0.009 DBMET03343 0.034 0.009 DBMET03344 0.033 0.011 DBMET03345 | DBMET03344 | |
| 0.047 | 0.038 | 0.047 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.022 | 0.013 | 0.022 | Imidazoline I1 receptor antagonist | |||
| 0.053 | 0.044 | 0.066 | 5 Hydroxytryptamine 3 antagonist | 0.057 0.039 DBMET03340 0.066 0.031 DBMET03342 | DBMET03342 | |
| 0.06 | 0.053 | 0.084 | Interferon inducer | 0.073 0.031 DBMET03343 0.063 0.046 DBMET03344 0.063 0.046 DBMET03345 0.084 0.02 DBMET03347 0.084 0.02 DBMET03350 0.084 0.02 DBMET03352 | DBMET03352 | |
| 0.047 | 0.039 | 0.061 | Prostaglandin E2 antagonist | 0.061 0.028 DBMET03339 0.048 0.037 DBMET03342 | DBMET03339 | |
| 0.104 | 0.096 | 0.231 | Alpha-N-acetylglucosaminidase inhibitor | 0.103 0.097 DBMET03341 0.118 0.079 DBMET03343 0.118 0.079 DBMET03344 0.118 0.079 DBMET03345 0.231 0.026 DBMET03347 0.231 0.026 DBMET03350 0.231 0.026 DBMET03352 | DBMET03352 | |
| 0.07 | 0.063 | 0.097 | Focal adhesion kinase 1 inhibitor | 0.097 0.032 DBMET03342 | DBMET03342 | |
| 0.072 | 0.066 | 0.103 | Interferon agonist | 0.088 0.041 DBMET03343 0.076 0.059 DBMET03344 0.076 0.059 DBMET03345 0.103 0.027 DBMET03347 0.103 0.027 DBMET03350 0.103 0.027 DBMET03352 | DBMET03352 | |
| 0.055 | 0.049 | 0.085 | Acetylcholine M2 receptor antagonist | 0.082 0.028 DBMET03340 0.085 0.027 DBMET03342 | DBMET03342 | |
| 0.065 | 0.059 | 0.078 | Protein kinase C beta inhibitor | 0.067 0.055 DBMET03343 0.078 0.034 DBMET03344 0.076 0.036 DBMET03345 | DBMET03344 | |
| 0.06 | 0.055 | 0.076 | Beta adrenoreceptor antagonist | 0.071 0.037 DBMET03343 0.071 0.037 DBMET03344 0.076 0.031 DBMET03345 | DBMET03345 | |
| 0.064 | 0.059 | 0.084 | MDM2 inhibitor | 0.084 0.016 DBMET03339 0.068 0.043 DBMET03341 0.064 0.058 DBMET03344 0.063 0.061 DBMET03345 | DBMET03339 | |
| 0.041 | 0.037 | 0.056 | Dihydrofolate reductase inhibitor | 0.056 0.013 DBMET03340 | DBMET03340 | |
| 0.036 | 0.032 | 0.042 | Vanilloid 3 antagonist | 0.042 0.018 DBMET03341 0.036 0.034 DBMET03342 0.036 0.035 DBMET03343 0.036 0.034 DBMET03344 | DBMET03341 | |
| 0.193 | 0.189 | 0.521 | Apoptosis antagonist | 0.208 0.169 DBMET03339 0.251 0.127 DBMET03341 0.204 0.174 DBMET03342 0.263 0.115 DBMET03343 0.278 0.102 DBMET03344 0.276 0.104 DBMET03345 0.415 0.034 DBMET03347 0.521 0.018 DBMET03350 0.455 0.027 DBMET03352 | DBMET03350 | |
| 0.078 | 0.075 | 0.09 | Estrogen-related receptor beta agonist | 0.089 0.043 DBMET03342 0.09 0.04 DBMET03343 0.09 0.04 DBMET03344 0.086 0.05 DBMET03345 | DBMET03344 | |
| 0.054 | 0.052 | 0.075 | Acetylcholine M5 receptor antagonist | 0.075 0.027 DBMET03342 0.055 0.05 DBMET03343 0.055 0.05 DBMET03344 0.054 0.053 DBMET03345 | DBMET03342 | |
| 0.122 | 0.12 | 0.134 | Sphingosine 1-phosphate receptor 5 antagonist | 0.124 0.115 DBMET03343 0.124 0.115 DBMET03344 0.134 0.091 DBMET03345 | DBMET03345 | |
| 0.033 | 0.031 | 0.049 | Adenosine uptake inhibitor | 0.035 0.023 DBMET03341 0.049 0.005 DBMET03342 0.043 0.008 DBMET03346 0.039 0.013 DBMET03349 0.038 0.016 DBMET03351 | DBMET03342 | |
| 0.174 | 0.172 | 0.257 | Neuropeptide Y2 antagonist | 0.241 0.065 DBMET03340 0.257 0.049 DBMET03341 | DBMET03341 | |
| 0.015 | 0.014 | 0.015 | Nicotinic alpha4 receptor agonist | |||
| 0.083 | 0.082 | 0.083 | Phosphodiesterase 7B inhibitor | |||
| 0.023 | 0.022 | 0.027 | 5 Hydroxytryptamine 4 agonist | 0.027 0.012 DBMET03341 | DBMET03341 | |
| 0.047 | 0.046 | 0.047 | Histamine agonist | 0.047 0.044 DBMET03342 | ||
| 0.031 | 0.031 | 0.042 | 5 Hydroxytryptamine 3B antagonist | 0.042 0.019 DBMET03342 | DBMET03342 | |
| 0.089 | 0.089 | 0.121 | EphA2 antagonist | 0.121 0.054 DBMET03339 0.115 0.06 DBMET03342 | DBMET03339 | |
| 0.015 | 0.016 | 0.018 | Sodium/hydrogen exchanger inhibitor | 0.017 0.012 DBMET03342 0.017 0.014 DBMET03349 0.018 0.012 DBMET03351 | DBMET03351 | |
| 0.104 | 0.105 | 0.11 | Sodium channel (voltage-gated) blocker | 0.11 0.096 DBMET03339 | DBMET03339 | |
| 0.049 | 0.05 | 0.068 | Dopamine uptake inhibitor | 0.068 0.032 DBMET03342 | DBMET03342 | |
| 0.095 | 0.096 | 0.12 | MAO inhibitor | 0.098 0.093 DBMET03340 0.118 0.075 DBMET03342 0.109 0.082 DBMET03343 0.12 0.075 DBMET03344 0.115 0.077 DBMET03345 | DBMET03344 | |
| 0.048 | 0.05 | 0.049 | Nicotinic receptor alpha7 subunit antagonist | 0.049 0.048 DBMET03342 | DBMET03342 | |
| 0.049 | 0.052 | 0.064 | EphB4 antagonist | 0.064 0.034 DBMET03342 | DBMET03342 | |
| 0.031 | 0.034 | 0.041 | Ceramide glucosyltransferase inhibitor | 0.041 0.015 DBMET03342 0.033 0.03 DBMET03343 0.033 0.03 DBMET03344 0.033 0.03 DBMET03345 | DBMET03342 | |
| 0.01 | 0.013 | 0.016 | Melatonin 2 antagonist | 0.016 0.004 DBMET03341 | DBMET03341 | |
| 0.072 | 0.078 | 0.092 | MAP kinase 7 inhibitor | 0.092 0.016 DBMET03342 | DBMET03342 | |
| 0.026 | 0.033 | 0.085 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.085 0.005 DBMET03341 0.037 0.018 DBMET03343 0.032 0.022 DBMET03344 0.042 0.015 DBMET03345 | DBMET03341 | |
| 0.032 | 0.039 | 0.036 | Alpha 1d adrenoreceptor agonist | 0.036 0.03 DBMET03345 | DBMET03345 | |
| 0.047 | 0.056 | 0.068 | Sphingosine kinase 2 inhibitor | 0.052 0.043 DBMET03343 0.068 0.024 DBMET03344 0.063 0.028 DBMET03345 | DBMET03344 | |
| 0.042 | 0.052 | 0.059 | Melanin-concentrating hormone receptor 1 antagonist | 0.059 0.03 DBMET03342 | DBMET03342 | |
| 0.038 | 0.048 | 0.179 | Phosphodiesterase 4A inhibitor | 0.179 0.008 DBMET03340 0.046 0.038 DBMET03342 | DBMET03340 | |
| 0.206 | 0.216 | 0.69 | Alpha-glucosidase inhibitor | 0.252 0.186 DBMET03341 0.216 0.208 DBMET03342 0.314 0.153 DBMET03343 0.366 0.129 DBMET03344 0.322 0.149 DBMET03345 0.629 0.048 DBMET03347 0.69 0.036 DBMET03350 0.581 0.058 DBMET03352 | DBMET03350 | |
| 0.051 | 0.062 | 0.104 | Phosphodiesterase III inhibitor | 0.104 0.021 DBMET03339 | DBMET03339 | |
| 0.088 | 0.099 | 0.097 | GABA C receptor antagonist | 0.097 0.083 DBMET03343 0.097 0.083 DBMET03344 | DBMET03344 | |
| 0.034 | 0.046 | 0.049 | Plasmepsin II inhibitor | 0.049 0.019 DBMET03341 | DBMET03341 | |
| 0.075 | 0.087 | 0.15 | NADH dehydrogenase inhibitor | 0.087 0.062 DBMET03343 0.087 0.062 DBMET03344 0.087 0.062 DBMET03345 0.15 0.018 DBMET03347 0.15 0.018 DBMET03350 0.15 0.018 DBMET03352 | DBMET03352 | |
| 0.046 | 0.058 | 0.093 | CXC chemokine 4 receptor antagonist | 0.093 0.026 DBMET03339 | DBMET03339 | |
| 0.071 | 0.084 | 0.099 | Phosphodiesterase 11A inhibitor | 0.099 0.033 DBMET03339 0.084 0.052 DBMET03342 | DBMET03339 | |
| 0.071 | 0.084 | 0.099 | Phosphodiesterase XI inhibitor | 0.099 0.033 DBMET03339 0.084 0.052 DBMET03342 | DBMET03339 | |
| 0.084 | 0.098 | 0.39 | AMP-activated protein kinase stimulant | 0.123 0.046 DBMET03343 0.117 0.052 DBMET03344 0.109 0.06 DBMET03345 0.299 0.005 DBMET03347 0.39 0.004 DBMET03350 0.294 0.005 DBMET03352 | DBMET03350 | |
| 0.03 | 0.044 | 0.095 | Substance P antagonist | 0.095 0.006 DBMET03340 | DBMET03340 | |
| 0.098 | 0.113 | 0.127 | Transcription factor STAT6 inhibitor | 0.127 0.048 DBMET03341 0.102 0.101 DBMET03343 0.106 0.089 DBMET03345 | DBMET03341 | |
| 0.07 | 0.084 | 0.09 | MAO B inhibitor | 0.087 0.068 DBMET03340 0.089 0.067 DBMET03342 0.09 0.066 DBMET03344 0.084 0.072 DBMET03345 | DBMET03344 | |
| 0.053 | 0.068 | 0.119 | Phosphodiesterase 4B inhibitor | 0.092 0.029 DBMET03339 0.119 0.018 DBMET03340 0.065 0.049 DBMET03341 | DBMET03340 | |
| 0.108 | 0.122 | 0.137 | Vanilloid 1 agonist | 0.129 0.068 DBMET03341 0.12 0.087 DBMET03343 0.12 0.087 DBMET03344 0.122 0.084 DBMET03345 0.137 0.054 DBMET03346 0.114 0.103 DBMET03347 0.137 0.054 DBMET03349 0.114 0.103 DBMET03350 0.123 0.081 DBMET03351 | DBMET03349 | |
| 0.043 | 0.058 | 0.058 | Beta 1 adrenoreceptor antagonist | 0.055 0.04 DBMET03343 0.058 0.037 DBMET03345 | DBMET03345 | |
| 0.057 | 0.074 | 0.117 | Histone deacetylase stimulant | 0.065 0.062 DBMET03343 0.065 0.061 DBMET03344 0.072 0.053 DBMET03345 0.117 0.019 DBMET03347 0.106 0.024 DBMET03350 0.108 0.023 DBMET03352 | DBMET03347 | |
| 0.057 | 0.074 | 0.117 | Histone deacetylase SIRT1 stimulant | 0.065 0.062 DBMET03343 0.065 0.061 DBMET03344 0.072 0.053 DBMET03345 0.117 0.019 DBMET03347 0.106 0.024 DBMET03350 0.108 0.023 DBMET03352 | DBMET03347 | |
| 0.178 | 0.195 | 0.231 | Insulysin inhibitor | 0.231 0.115 DBMET03339 0.192 0.17 DBMET03344 0.203 0.153 DBMET03345 | DBMET03339 | |
| 0.04 | 0.057 | 0.058 | Topoisomerase II beta inhibitor | 0.058 0.024 DBMET03343 0.048 0.036 DBMET03344 0.05 0.033 DBMET03345 | DBMET03343 | |
| 0.134 | 0.152 | 0.167 | Potassium channel blocker | 0.167 0.118 DBMET03342 | DBMET03342 | |
| 0.009 | 0.026 | 0.015 | Melatonin receptor 1A antagonist | 0.015 0.008 DBMET03340 0.013 0.01 DBMET03341 | DBMET03340 | |
| 0.05 | 0.068 | 0.068 | Fibroblast growth factor 2 antagonist | 0.068 0.043 DBMET03342 | DBMET03342 | |
| 0.121 | 0.14 | 0.132 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.132 0.112 DBMET03342 0.132 0.111 DBMET03345 | DBMET03345 | |
| 0.076 | 0.094 | 0.102 | Polo-like kinase-1 inhibitor | 0.092 0.057 DBMET03339 0.084 0.074 DBMET03340 0.102 0.044 DBMET03342 | DBMET03342 | |
| 0.072 | 0.091 | 0.09 | Antihistaminic | 0.09 0.064 DBMET03342 | DBMET03342 | |
| 0.037 | 0.057 | 0.056 | Beta 2 adrenoreceptor antagonist | 0.051 0.034 DBMET03343 0.045 0.044 DBMET03344 0.056 0.029 DBMET03345 | DBMET03345 | |
| 0.077 | 0.098 | 0.118 | Gastric antisecretory | 0.097 0.07 DBMET03342 0.11 0.053 DBMET03346 0.118 0.045 DBMET03349 0.114 0.049 DBMET03351 | DBMET03349 | |
| 0.089 | 0.11 | 0.245 | RET inhibitor | 0.245 0.032 DBMET03340 0.115 0.083 DBMET03342 | DBMET03340 | |
| 0.08 | 0.101 | 0.125 | Nav1.1 sodium channel blocker | 0.125 0.045 DBMET03339 0.099 0.067 DBMET03342 | DBMET03339 | |
| 0.055 | 0.077 | 0.069 | Amidase inhibitor | 0.064 0.058 DBMET03341 0.069 0.05 DBMET03342 | DBMET03342 | |
| 0.09 | 0.112 | 0.106 | Protein-tyrosine kinase Lyn inhibitor | 0.106 0.097 DBMET03342 | DBMET03342 | |
| 0.068 | 0.092 | 0.104 | Platelet activating factor beta antagonist | 0.104 0.06 DBMET03342 | DBMET03342 | |
| 0.03 | 0.055 | 0.129 | Neurokinin 1 antagonist | 0.129 0.005 DBMET03340 | DBMET03340 | |
| 0.036 | 0.062 | 0.162 | Neurokinin antagonist | 0.162 0.005 DBMET03340 | DBMET03340 | |
| 0.099 | 0.128 | 0.264 | Peroxidase inhibitor | 0.163 0.072 DBMET03343 0.264 0.044 DBMET03344 0.261 0.045 DBMET03345 | DBMET03344 | |
| 0.068 | 0.099 | 0.119 | HIV-1 integrase (Overall Integration) inhibitor | 0.119 0.04 DBMET03343 0.118 0.04 DBMET03344 0.117 0.041 DBMET03345 | DBMET03343 | |
| 0.15 | 0.181 | 0.208 | ErbB-1 antagonist | 0.208 0.081 DBMET03342 | DBMET03342 | |
| 0.071 | 0.103 | 0.126 | ATPase (Vacuolar H+) inhibitor | 0.107 0.031 DBMET03343 0.107 0.032 DBMET03344 0.09 0.056 DBMET03345 0.126 0.016 DBMET03347 0.126 0.016 DBMET03350 0.123 0.018 DBMET03352 | DBMET03350 | |
| 0.061 | 0.093 | 0.078 | Histamine antagonist | 0.078 0.066 DBMET03342 | DBMET03342 | |
| 0.074 | 0.111 | 0.188 | Polo-like kinase-4 inhibitor | 0.188 0.019 DBMET03339 0.108 0.068 DBMET03342 | DBMET03339 | |
| 0.214 | 0.251 | 0.444 | Calcium channel L-type activator | 0.444 0.054 DBMET03339 0.305 0.153 DBMET03343 0.305 0.153 DBMET03344 0.305 0.153 DBMET03345 | DBMET03339 | |
| 0.066 | 0.104 | 0.311 | Bronchodilator | 0.311 0.008 DBMET03340 0.09 0.075 DBMET03342 0.098 0.066 DBMET03344 | DBMET03340 | |
| 0.096 | 0.134 | 0.126 | Sphingosine 1-phosphate receptor 4 antagonist | 0.111 0.092 DBMET03339 0.126 0.062 DBMET03341 | DBMET03341 | |
| 0.11 | 0.148 | 0.28 | Heat shock protein 90 alpha antagonist | 0.28 0.018 DBMET03340 0.132 0.108 DBMET03341 0.123 0.122 DBMET03342 0.19 0.056 DBMET03343 0.129 0.113 DBMET03344 0.159 0.078 DBMET03345 | DBMET03340 | |
| 0.175 | 0.213 | 0.196 | MAP kinase kinase 3 inhibitor | 0.196 0.135 DBMET03339 | DBMET03339 | |
| 0.026 | 0.064 | 0.044 | Glycine transporter 2 inhibitor | 0.044 0.035 DBMET03342 | DBMET03342 | |
| 0.051 | 0.09 | 0.065 | Beta 3 adrenoreceptor antagonist | 0.06 0.054 DBMET03343 0.065 0.043 DBMET03345 | DBMET03345 | |
| 0.128 | 0.167 | 0.177 | Death-associated protein kinase 2 inhibitor | 0.147 0.114 DBMET03343 0.147 0.114 DBMET03344 0.177 0.058 DBMET03345 | DBMET03345 | |
| 0.029 | 0.069 | 0.097 | Mannosidase inhibitor | 0.097 0.006 DBMET03347 0.097 0.006 DBMET03350 0.097 0.006 DBMET03352 | DBMET03352 | |
| 0.023 | 0.063 | 0.059 | Dopamine D2 agonist | 0.053 0.025 DBMET03345 0.043 0.032 DBMET03349 0.059 0.022 DBMET03351 | DBMET03351 | |
| 0.062 | 0.101 | 0.095 | Fibroblast growth factor 1 antagonist | 0.087 0.068 DBMET03340 0.095 0.061 DBMET03342 | DBMET03342 | |
| 0.029 | 0.069 | 0.171 | GHS receptor agonist | 0.171 0.004 DBMET03340 | DBMET03340 | |
| 0.065 | 0.105 | 0.082 | Platelet activating factor alpha antagonist | 0.082 0.078 DBMET03342 | DBMET03342 | |
| 0.028 | 0.069 | 0.055 | Potassium channel Kv1.3 blocker | 0.055 0.025 DBMET03341 | DBMET03341 | |
| 0.074 | 0.115 | 0.107 | Glutamate release inhibitor | 0.107 0.033 DBMET03342 | DBMET03342 | |
| 0.019 | 0.061 | 0.032 | Epoxide hydrolase 1 inhibitor | 0.032 0.02 DBMET03341 | DBMET03341 | |
| 0.016 | 0.058 | 0.03 | ICAM 1 antagonist | 0.03 0.006 DBMET03340 0.025 0.012 DBMET03341 | DBMET03340 | |
| 0.079 | 0.121 | 0.106 | Cholesterol synthesis inhibitor | 0.106 0.079 DBMET03341 0.096 0.093 DBMET03343 0.096 0.093 DBMET03344 0.097 0.091 DBMET03345 0.095 0.094 DBMET03346 0.095 0.094 DBMET03349 | DBMET03341 | |
| 0.023 | 0.066 | 0.033 | Estrogen-related receptor beta antagonist | 0.033 0.021 DBMET03343 0.033 0.021 DBMET03344 0.033 0.021 DBMET03345 | DBMET03345 | |
| 0.046 | 0.089 | 0.078 | Histidine decarboxylase inhibitor | 0.067 0.054 DBMET03343 0.078 0.044 DBMET03345 | DBMET03345 | |
| 0.038 | 0.081 | 0.182 | Phosphodiesterase 7A inhibitor | 0.054 0.032 DBMET03339 0.182 0.003 DBMET03340 | DBMET03340 | |
| 0.075 | 0.119 | 0.093 | Carbonic anhydrase XV inhibitor | 0.093 0.078 DBMET03345 | DBMET03345 | |
| 0.037 | 0.081 | 0.09 | Alpha-mannosidase inhibitor | 0.09 0.008 DBMET03347 0.09 0.008 DBMET03350 0.09 0.008 DBMET03352 | DBMET03352 | |
| 0.052 | 0.097 | 0.063 | Beta 2 adrenoreceptor agonist | 0.059 0.056 DBMET03343 0.062 0.043 DBMET03344 0.063 0.038 DBMET03345 | DBMET03345 | |
| 0.166 | 0.211 | 0.354 | Beta lactamase inhibitor | 0.195 0.189 DBMET03339 0.312 0.13 DBMET03340 0.354 0.114 DBMET03341 0.226 0.169 DBMET03342 | DBMET03341 | |
| 0.035 | 0.082 | 0.057 | Protein kinase C eta inhibitor | 0.051 0.042 DBMET03339 0.057 0.036 DBMET03344 | DBMET03344 | |
| 0.055 | 0.103 | 0.081 | Ca(v)2.2 blocker | 0.081 0.064 DBMET03341 | DBMET03341 | |
| 0.041 | 0.09 | 0.08 | Lipase inhibitor | 0.08 0.043 DBMET03339 0.077 0.046 DBMET03342 0.08 0.043 DBMET03344 0.068 0.056 DBMET03345 | DBMET03344 | |
| 0.099 | 0.15 | 0.139 | Mannose-6-phosphate isomerase inhibitor | 0.139 0.075 DBMET03343 0.122 0.098 DBMET03344 0.119 0.102 DBMET03345 0.118 0.104 DBMET03347 | DBMET03343 | |
| 0.056 | 0.107 | 0.098 | Potassium channel (Tandem pore domain) blocker | 0.098 0.01 DBMET03341 | DBMET03341 | |
| 0.012 | 0.064 | 0.024 | Antibiotic Anthracycline-like | 0.024 0.006 DBMET03347 0.024 0.006 DBMET03350 0.024 0.006 DBMET03352 | DBMET03352 | |
| 0.047 | 0.1 | 0.071 | CXC chemokine receptor antagonist | 0.071 0.048 DBMET03339 | DBMET03339 | |
| 0.049 | 0.103 | 0.085 | Glutamate (mGluR7) antagonist | 0.085 0.022 DBMET03342 | DBMET03342 | |
| 0.037 | 0.091 | 0.046 | Sodium/calcium exchanger inhibitor | 0.046 0.045 DBMET03339 | DBMET03339 | |
| 0.054 | 0.109 | 0.149 | Phosphodiesterase VIII inhibitor | 0.149 0.003 DBMET03340 | DBMET03340 | |
| 0.081 | 0.136 | 0.118 | TRPA1 agonist | 0.118 0.061 DBMET03346 0.118 0.061 DBMET03349 0.114 0.065 DBMET03351 | DBMET03349 | |
| 0.079 | 0.135 | 0.104 | Epidermal growth factor receptor kinase inhibitor | 0.104 0.092 DBMET03342 | DBMET03342 | |
| 0.049 | 0.105 | 0.095 | MAP-kinase-activated kinase 2 inhibitor | 0.095 0.031 DBMET03339 | DBMET03339 | |
| 0.181 | 0.239 | 0.33 | DNA polymerase beta inhibitor | 0.33 0.149 DBMET03341 0.243 0.197 DBMET03342 0.23 0.205 DBMET03343 0.238 0.2 DBMET03344 | DBMET03341 | |
| 0.041 | 0.098 | 0.058 | Sphingosine kinase inhibitor | 0.058 0.042 DBMET03344 0.054 0.051 DBMET03345 | DBMET03344 | |
| 0.054 | 0.113 | 0.069 | Keratolytic | 0.069 0.066 DBMET03344 0.069 0.068 DBMET03345 | DBMET03345 | |
| 0.049 | 0.11 | 0.121 | Platelet growth factor antagonist | 0.121 0.029 DBMET03340 0.075 0.062 DBMET03342 | DBMET03340 | |
| 0.008 | 0.069 | 0.017 | Melatonin 1 antagonist | 0.017 0.016 DBMET03340 | DBMET03340 | |
| 0.055 | 0.117 | 0.105 | MAP-kinase-activated kinase inhibitor | 0.105 0.035 DBMET03339 | DBMET03339 | |
| 0.108 | 0.17 | 0.238 | Interferon gamma antagonist | 0.141 0.091 DBMET03343 0.128 0.115 DBMET03345 0.216 0.036 DBMET03347 0.189 0.045 DBMET03350 0.238 0.031 DBMET03352 | DBMET03352 | |
| 0.065 | 0.127 | 0.079 | Ca(v)3.1 blocker | 0.079 0.064 DBMET03341 | DBMET03341 | |
| 0.108 | 0.171 | 0.137 | Pregnane X receptor agonist | 0.133 0.091 DBMET03342 0.137 0.08 DBMET03346 0.137 0.08 DBMET03349 0.134 0.088 DBMET03351 | DBMET03349 | |
| 0.011 | 0.073 | 0.026 | Melatonin antagonist | 0.026 0.022 DBMET03340 | DBMET03340 | |
| 0.066 | 0.129 | 0.086 | D-Ala-D-Ala ligase inhibitor | 0.078 0.076 DBMET03343 0.078 0.076 DBMET03344 0.086 0.053 DBMET03345 | DBMET03345 | |
| 0.068 | 0.132 | 0.123 | Anesthetic local | 0.123 0.065 DBMET03342 | DBMET03342 | |
| 0.062 | 0.125 | 0.119 | Creatine kinase inhibitor | 0.093 0.067 DBMET03343 0.093 0.067 DBMET03344 0.119 0.042 DBMET03345 | DBMET03345 | |
| 0.06 | 0.125 | 0.089 | Prolactin inhibitor | 0.084 0.074 DBMET03342 0.089 0.068 DBMET03345 | DBMET03345 | |
| 0.011 | 0.076 | 0.025 | Dopamine D1 agonist | 0.025 0.013 DBMET03345 0.021 0.019 DBMET03350 0.022 0.018 DBMET03352 | DBMET03345 | |
| 0.044 | 0.11 | 0.064 | Bcl2 antagonist | 0.062 0.052 DBMET03342 0.064 0.049 DBMET03343 | DBMET03343 | |
| 0.005 | 0.071 | 0.021 | Ileal bile acid transport inhibitor | 0.021 0.008 DBMET03347 0.016 0.013 DBMET03350 0.017 0.012 DBMET03352 | DBMET03347 | |
| 0.063 | 0.13 | 0.164 | UDP-glucose 4-epimerase inhibitor | 0.164 0.025 DBMET03347 0.164 0.025 DBMET03350 0.164 0.025 DBMET03352 | DBMET03352 | |
| 0.033 | 0.101 | 0.265 | Phosphodiesterase VII inhibitor | 0.265 0.004 DBMET03340 | DBMET03340 | |
| 0.121 | 0.189 | 0.264 | Neurotrophic factor enhancer | 0.264 0.031 DBMET03340 0.19 0.087 DBMET03343 0.152 0.135 DBMET03344 0.163 0.12 DBMET03345 0.164 0.118 DBMET03347 0.164 0.118 DBMET03350 0.172 0.107 DBMET03352 | DBMET03340 | |
| 0.019 | 0.089 | 0.044 | Cyclin D3 inhibitor | 0.044 0.024 DBMET03340 | DBMET03340 | |
| 0.151 | 0.221 | 0.417 | Cholesterol antagonist | 0.223 0.145 DBMET03342 0.255 0.121 DBMET03343 0.196 0.168 DBMET03345 0.417 0.046 DBMET03347 0.351 0.064 DBMET03350 0.363 0.059 DBMET03352 | DBMET03347 | |
| 0.018 | 0.089 | 0.033 | Toll-Like receptor 4 agonist | 0.028 0.014 DBMET03346 0.033 0.009 DBMET03347 0.026 0.02 DBMET03349 0.031 0.01 DBMET03350 0.026 0.019 DBMET03351 0.031 0.01 DBMET03352 | DBMET03347 | |
| 0.025 | 0.096 | 0.052 | Carbonic anhydrase XIV inhibitor | 0.046 0.038 DBMET03347 0.052 0.031 DBMET03350 0.044 0.04 DBMET03352 | DBMET03350 | |
| 0.017 | 0.089 | 0.048 | Estradiol 17 beta-dehydrogenase inhibitor | 0.048 0.026 DBMET03341 | DBMET03341 | |
| 0.015 | 0.088 | 0.056 | Dopamine D5 antagonist | 0.056 0.021 DBMET03342 | DBMET03342 | |
| 0.095 | 0.17 | 0.124 | Arachidonic acid antagonist | 0.124 0.12 DBMET03345 | DBMET03345 | |
| 0.071 | 0.147 | 0.165 | Toll-Like receptor 4 antagonist | 0.11 0.055 DBMET03344 0.095 0.078 DBMET03345 0.153 0.019 DBMET03347 0.165 0.014 DBMET03350 0.162 0.015 DBMET03352 | DBMET03350 | |
| 0.139 | 0.218 | 0.27 | Thyroid hormone beta antagonist | 0.251 0.118 DBMET03339 0.226 0.134 DBMET03340 0.27 0.105 DBMET03341 | DBMET03341 | |
| 0.063 | 0.142 | 0.124 | Cystathionine beta-synthase inhibitor | 0.106 0.071 DBMET03342 0.095 0.083 DBMET03343 0.124 0.055 DBMET03344 0.124 0.055 DBMET03345 | DBMET03345 | |
| 0.015 | 0.094 | 0.03 | Phosphodiesterase 6B inhibitor | 0.03 0.021 DBMET03342 | DBMET03342 | |
| 0.013 | 0.093 | 0.022 | Phosphodiesterase 6G inhibitor | 0.022 0.021 DBMET03342 | DBMET03342 | |
| 0.013 | 0.093 | 0.022 | Phosphodiesterase 6H inhibitor | 0.022 0.021 DBMET03342 | DBMET03342 | |
| 0.035 | 0.117 | 0.051 | Vanilloid 2 antagonist | 0.051 0.039 DBMET03345 | DBMET03345 | |
| 0.013 | 0.095 | 0.041 | CXC chemokine 3 receptor antagonist | 0.041 0.013 DBMET03340 0.032 0.02 DBMET03341 | DBMET03340 | |
| 0.029 | 0.111 | 0.044 | Benzodiazepine antagonist | 0.044 0.041 DBMET03341 | DBMET03341 | |
| 0.126 | 0.211 | 0.207 | Cardiotonic | 0.207 0.112 DBMET03340 | DBMET03340 | |
| 0.045 | 0.13 | 0.075 | Bcr-Abl kinase inhibitor | 0.075 0.071 DBMET03342 | DBMET03342 | |
| 0.055 | 0.14 | 0.1 | Sphingomyelinase inhibitor | 0.1 0.06 DBMET03342 | DBMET03342 | |
| 0.012 | 0.098 | 0.04 | Glutamate (mGluR2) agonist | 0.04 0.018 DBMET03340 | DBMET03340 | |
| 0.136 | 0.222 | 0.228 | Lipoxygenase inhibitor | 0.212 0.129 DBMET03340 0.219 0.122 DBMET03343 0.228 0.116 DBMET03344 0.228 0.116 DBMET03345 | DBMET03345 | |
| 0.034 | 0.12 | 0.048 | Phosphodiesterase 6C inhibitor | 0.048 0.026 DBMET03342 | DBMET03342 | |
| 0.015 | 0.101 | 0.044 | Glutamate (mGluR group II) agonist | 0.044 0.018 DBMET03340 | DBMET03340 | |
| 0.066 | 0.155 | 0.157 | Alkylator | 0.136 0.054 DBMET03347 0.144 0.05 DBMET03350 0.157 0.043 DBMET03352 | DBMET03352 | |
| 0.007 | 0.097 | 0.044 | Arginase inhibitor | 0.044 0.019 DBMET03347 0.044 0.019 DBMET03350 0.043 0.02 DBMET03352 | DBMET03350 | |
| 0.036 | 0.126 | 0.111 | Carbonic anhydrase XIII inhibitor | 0.098 0.039 DBMET03346 0.065 0.063 DBMET03347 0.075 0.054 DBMET03349 0.111 0.033 DBMET03351 | DBMET03351 | |
| 0.058 | 0.15 | 0.096 | Insulin receptor antagonist | 0.096 0.066 DBMET03340 | DBMET03340 | |
| 0.057 | 0.15 | 0.233 | Topoisomerase II inhibitor | 0.128 0.061 DBMET03343 0.186 0.037 DBMET03344 0.107 0.079 DBMET03345 0.233 0.027 DBMET03347 0.215 0.03 DBMET03350 0.216 0.03 DBMET03352 | DBMET03347 | |
| 0.071 | 0.165 | 0.105 | DOPA decarboxylase inhibitor | 0.105 0.067 DBMET03343 0.105 0.067 DBMET03344 0.105 0.066 DBMET03345 | DBMET03345 | |
| 0.036 | 0.131 | 0.093 | Na+ K+ transporting ATPase inhibitor | 0.093 0.038 DBMET03347 0.093 0.038 DBMET03350 0.091 0.04 DBMET03352 | DBMET03350 | |
| 0.164 | 0.259 | 0.281 | DNA directed DNA polymerase inhibitor | 0.281 0.172 DBMET03341 0.224 0.209 DBMET03343 0.232 0.203 DBMET03344 | DBMET03341 | |
| 0.012 | 0.108 | 0.044 | Trypsin II inhibitor | 0.044 0.011 DBMET03340 | DBMET03340 | |
| 0.147 | 0.243 | 0.38 | Angiogenesis inhibitor | 0.194 0.177 DBMET03339 0.272 0.108 DBMET03346 0.2 0.17 DBMET03347 0.227 0.141 DBMET03349 0.226 0.142 DBMET03350 0.38 0.059 DBMET03351 0.201 0.168 DBMET03352 | DBMET03351 | |
| 0.051 | 0.148 | 0.154 | Mediator release inhibitor | 0.142 0.032 DBMET03347 0.143 0.032 DBMET03350 0.154 0.027 DBMET03352 | DBMET03352 | |
| 0.044 | 0.14 | 0.107 | HIV-1 integrase inhibitor | 0.095 0.028 DBMET03343 0.107 0.021 DBMET03344 0.101 0.024 DBMET03345 0.064 0.059 DBMET03346 0.067 0.053 DBMET03349 0.087 0.033 DBMET03351 | DBMET03344 | |
| 0.133 | 0.23 | 0.26 | Thyroid hormone antagonist | 0.243 0.128 DBMET03339 0.215 0.149 DBMET03340 0.26 0.117 DBMET03341 | DBMET03341 | |
| 0.058 | 0.157 | 0.082 | Bromodomain-containing protein 2 inhibitor | 0.082 0.071 DBMET03341 | DBMET03341 | |
| 0.017 | 0.116 | 0.05 | Phosphodiesterase 3B inhibitor | 0.05 0.025 DBMET03339 | DBMET03339 | |
| 0.043 | 0.143 | 0.078 | Potassium channel (Ca-activated) activator | 0.078 0.077 DBMET03345 | DBMET03345 | |
| 0.051 | 0.155 | 0.071 | Vanilloid 4 agonist | 0.071 0.063 DBMET03342 | DBMET03342 | |
| 0.006 | 0.112 | 0.029 | Follicle-stimulating hormone agonist | 0.029 0.01 DBMET03341 | DBMET03341 | |
| 0.054 | 0.163 | 0.106 | Triose-phosphate isomerase inhibitor | 0.106 0.043 DBMET03347 0.106 0.043 DBMET03350 0.106 0.043 DBMET03352 | DBMET03352 | |
| 0.057 | 0.169 | 0.091 | Carbonic anhydrase III inhibitor | 0.091 0.073 DBMET03344 | DBMET03344 | |
| 0.041 | 0.157 | 0.064 | Bcl-xL inhibitor | 0.064 0.03 DBMET03343 | DBMET03343 | |
| 0.011 | 0.13 | 0.051 | Sodium/glucose cotransporter inhibitor | 0.046 0.005 DBMET03347 0.043 0.006 DBMET03350 0.051 0.005 DBMET03352 | DBMET03352 | |
| 0.011 | 0.131 | 0.027 | Follicle-stimulating hormone antagonist | 0.027 0.005 DBMET03340 | DBMET03340 | |
| 0.051 | 0.172 | 0.124 | DNA intercalator | 0.124 0.055 DBMET03347 0.119 0.058 DBMET03350 0.115 0.061 DBMET03352 | DBMET03347 | |
| 0.02 | 0.141 | 0.045 | CC chemokine 5 receptor antagonist | 0.045 0.044 DBMET03341 | DBMET03341 | |
| 0.029 | 0.155 | 0.052 | Fatty acid synthase inhibitor | 0.052 0.049 DBMET03341 | DBMET03341 | |
| 0.028 | 0.154 | 0.09 | Heparanase inhibitor | 0.09 0.005 DBMET03347 0.087 0.005 DBMET03350 0.088 0.005 DBMET03352 | DBMET03347 | |
| 0.104 | 0.23 | 0.236 | ATPase inhibitor | 0.143 0.114 DBMET03343 0.236 0.017 DBMET03347 0.223 0.023 DBMET03350 0.217 0.026 DBMET03352 | DBMET03347 | |
| 0.066 | 0.193 | 0.105 | Photosensitizer | 0.105 0.079 DBMET03347 0.105 0.079 DBMET03350 0.102 0.085 DBMET03352 | DBMET03350 | |
| 0.093 | 0.223 | 0.171 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.147 0.146 DBMET03342 0.171 0.121 DBMET03343 | DBMET03343 | |
| 0.015 | 0.148 | 0.16 | Neurokinin 2 antagonist | 0.16 0.005 DBMET03340 | DBMET03340 | |
| 0.04 | 0.175 | 0.214 | Topoisomerase I inhibitor | 0.126 0.052 DBMET03340 0.124 0.053 DBMET03344 0.214 0.023 DBMET03347 0.205 0.025 DBMET03350 0.199 0.027 DBMET03352 | DBMET03347 | |
| 0.122 | 0.258 | 0.217 | Thioredoxin glutathione reductase inhibitor | 0.19 0.181 DBMET03340 0.217 0.157 DBMET03341 | DBMET03341 | |
| 0.019 | 0.155 | 0.045 | Plasminogen activator inhibitor antagonist | 0.045 0.04 DBMET03343 0.045 0.039 DBMET03347 | DBMET03347 | |
| 0.067 | 0.207 | 0.295 | Cell adhesion inhibitor | 0.106 0.079 DBMET03341 0.211 0.022 DBMET03346 0.295 0.01 DBMET03347 0.174 0.033 DBMET03349 0.209 0.022 DBMET03350 0.191 0.027 DBMET03351 0.222 0.019 DBMET03352 | DBMET03347 | |
| 0.032 | 0.172 | 0.064 | Cathepsin G inhibitor | 0.064 0.062 DBMET03346 0.064 0.062 DBMET03349 | DBMET03349 | |
| 0.042 | 0.183 | 0.093 | Vascular endothelial growth factor 1 antagonist | 0.093 0.071 DBMET03340 | DBMET03340 | |
| 0.01 | 0.154 | 0.074 | Factor Xa inhibitor | 0.074 0.019 DBMET03349 0.061 0.024 DBMET03351 | DBMET03349 | |
| 0.016 | 0.165 | 0.04 | Acetyl-CoA carboxylase inhibitor | 0.04 0.031 DBMET03341 | DBMET03341 | |
| 0.045 | 0.197 | 0.212 | Cell adhesion molecule inhibitor | 0.072 0.066 DBMET03341 0.212 0.009 DBMET03346 0.163 0.013 DBMET03347 0.18 0.011 DBMET03349 0.109 0.029 DBMET03350 0.195 0.01 DBMET03351 0.113 0.027 DBMET03352 | DBMET03346 | |
| 0.007 | 0.16 | 0.045 | Sodium/glucose cotransporter 2 inhibitor | 0.039 0.009 DBMET03347 0.038 0.009 DBMET03350 0.045 0.007 DBMET03352 | DBMET03352 | |
| 0.02 | 0.18 | 0.069 | Phosphofructokinase-1 inhibitor | 0.069 0.048 DBMET03347 0.069 0.048 DBMET03350 0.069 0.048 DBMET03352 | DBMET03352 | |
| 0.028 | 0.191 | 0.118 | Cyclin B3 inhibitor | 0.118 0.022 DBMET03340 | DBMET03340 | |
| 0.025 | 0.188 | 0.082 | Glucose-6-phosphate translocase inhibitor | 0.082 0.01 DBMET03347 0.082 0.01 DBMET03350 0.082 0.01 DBMET03352 | DBMET03352 | |
| 0.041 | 0.21 | 0.261 | Antineoplastic alkaloid | 0.261 0.004 DBMET03340 | DBMET03340 | |
| 0.021 | 0.195 | 0.049 | NMDA 2B receptor antagonist | 0.049 0.045 DBMET03346 0.049 0.045 DBMET03349 | DBMET03349 | |
| 0.131 | 0.306 | 0.239 | Sodium/bile acid cotransporter inhibitor | 0.202 0.185 DBMET03339 0.239 0.14 DBMET03343 0.202 0.185 DBMET03345 | DBMET03343 | |
| 0.072 | 0.25 | 0.193 | Hexokinase inhibitor | 0.193 0.04 DBMET03347 0.172 0.056 DBMET03350 0.179 0.05 DBMET03352 | DBMET03347 | |
| 0.014 | 0.198 | 0.069 | Aldose reductase inhibitor | 0.063 0.03 DBMET03347 0.069 0.028 DBMET03350 0.063 0.031 DBMET03352 | DBMET03350 | |
| 0.027 | 0.216 | 0.124 | Topoisomerase II alpha inhibitor | 0.07 0.062 DBMET03343 0.089 0.047 DBMET03344 0.124 0.029 DBMET03347 0.117 0.031 DBMET03350 0.115 0.032 DBMET03352 | DBMET03347 | |
| 0.128 | 0.317 | 0.27 | Transcription factor inhibitor | 0.27 0.173 DBMET03341 | DBMET03341 | |
| 0.025 | 0.218 | 0.065 | Cyclin H inhibitor | 0.065 0.034 DBMET03340 | DBMET03340 | |
| 0.08 | 0.274 | 0.237 | Non-steroidal antiinflammatory agent | 0.214 0.061 DBMET03347 0.188 0.081 DBMET03350 0.237 0.049 DBMET03352 | DBMET03352 | |
| 0.028 | 0.223 | 0.051 | Factor III inhibitor | 0.051 0.033 DBMET03347 0.051 0.033 DBMET03350 0.048 0.04 DBMET03352 | DBMET03350 | |
| 0.064 | 0.265 | 0.16 | MAP3K9 inhibitor | 0.16 0.046 DBMET03339 | DBMET03339 | |
| 0.061 | 0.272 | 0.223 | Cell wall synthesis inhibitor | 0.223 0.022 DBMET03347 0.223 0.022 DBMET03350 0.142 0.073 DBMET03351 0.216 0.024 DBMET03352 | DBMET03350 | |
| 0.128 | 0.339 | 0.626 | Antibacterial | 0.23 0.196 DBMET03340 0.219 0.208 DBMET03344 0.217 0.21 DBMET03345 0.614 0.017 DBMET03347 0.626 0.016 DBMET03350 0.62 0.016 DBMET03352 | DBMET03350 | |
| 0.042 | 0.254 | 0.094 | Xanthine oxidase inhibitor | 0.088 0.075 DBMET03347 0.094 0.066 DBMET03352 | DBMET03352 | |
| 0.029 | 0.243 | 0.071 | Protein kinase B gamma inhibitor | 0.071 0.056 DBMET03349 | DBMET03349 | |
| 0.008 | 0.222 | 0.036 | Catechol O-methyltransferase inhibitor | 0.036 0.018 DBMET03343 0.036 0.018 DBMET03345 | DBMET03345 | |
| 0.014 | 0.23 | 0.066 | HIV-1 integrase (Strand Transfer) inhibitor | 0.066 0.038 DBMET03343 0.064 0.039 DBMET03344 0.065 0.039 DBMET03351 | DBMET03343 | |
| 0.029 | 0.248 | 0.082 | 5-Lipoxygenase inhibitor | 0.082 0.079 DBMET03345 | DBMET03345 | |
| 0.118 | 0.34 | 0.252 | Toll-Like receptor 7 agonist | 0.252 0.146 DBMET03352 | DBMET03352 | |
| 0.114 | 0.348 | 0.267 | Toll-Like receptor agonist | 0.267 0.133 DBMET03352 | DBMET03352 | |
| 0.047 | 0.285 | 0.123 | Neurotrophic factor | 0.112 0.109 DBMET03341 0.123 0.091 DBMET03343 | DBMET03343 | |
| 0.015 | 0.255 | 0.073 | HIV-1 integrase (3'-Processing) inhibitor | 0.069 0.04 DBMET03343 0.073 0.037 DBMET03344 0.061 0.046 DBMET03345 0.064 0.043 DBMET03351 | DBMET03344 | |
| 0.052 | 0.295 | 0.082 | T cell inhibitor | 0.082 0.06 DBMET03347 0.079 0.071 DBMET03350 0.079 0.07 DBMET03352 | DBMET03347 | |
| 0.01 | 0.267 | 0.166 | Antineoplastic antibiotic | 0.164 0.028 DBMET03347 0.166 0.028 DBMET03350 0.161 0.029 DBMET03352 | DBMET03350 | |
| 0.044 | 0.308 | 0.086 | Vanilloid agonist | 0.086 0.055 DBMET03346 0.086 0.055 DBMET03349 | DBMET03349 | |
| 0.06 | 0.326 | 0.32 | Platelet antagonist | 0.299 0.053 DBMET03346 0.32 0.046 DBMET03347 0.27 0.064 DBMET03350 0.159 0.135 DBMET03351 0.291 0.055 DBMET03352 | DBMET03347 | |
| 0.051 | 0.322 | 0.141 | Interleukin 4 antagonist | 0.141 0.058 DBMET03343 0.12 0.086 DBMET03345 0.123 0.081 DBMET03347 0.123 0.081 DBMET03350 0.113 0.096 DBMET03352 | DBMET03343 | |
| 0.004 | 0.276 | 0.13 | Cholecystokinin A agonist | 0.123 0.004 DBMET03346 0.13 0.003 DBMET03349 0.128 0.003 DBMET03351 | DBMET03349 | |
| 0.097 | 0.375 | 0.35 | Antiobesity | 0.263 0.145 DBMET03346 0.223 0.183 DBMET03347 0.35 0.087 DBMET03349 | DBMET03349 | |
| 0.036 | 0.315 | 0.099 | Thioredoxin inhibitor | 0.099 0.049 DBMET03347 0.091 0.06 DBMET03350 0.092 0.059 DBMET03352 | DBMET03347 | |
| 0.007 | 0.292 | 0.051 | Phosphodiesterase II inhibitor | 0.051 0.046 DBMET03339 | DBMET03339 | |
| 0.022 | 0.307 | 0.154 | M18 aspartyl aminopeptidase inhibitor | 0.154 0.05 DBMET03345 | DBMET03345 | |
| 0.004 | 0.315 | 0.17 | Cholecystokinin agonist | 0.16 0.003 DBMET03346 0.17 0.003 DBMET03349 0.167 0.003 DBMET03351 | DBMET03349 | |
| 0.047 | 0.359 | 0.415 | Immunostimulant | 0.378 0.056 DBMET03347 0.415 0.045 DBMET03350 0.361 0.061 DBMET03352 | DBMET03350 | |
| 0.013 | 0.33 | 0.093 | Protein 50S ribosomal subunit inhibitor | 0.093 0.015 DBMET03347 0.092 0.015 DBMET03350 0.093 0.015 DBMET03352 | DBMET03352 | |
| 0.073 | 0.391 | 0.573 | Hypoglycemic | 0.573 0.01 DBMET03347 0.555 0.011 DBMET03350 0.56 0.011 DBMET03352 | DBMET03347 | |
| 0.015 | 0.346 | 0.112 | MAP3K7 inhibitor | 0.112 0.016 DBMET03341 | DBMET03341 | |
| 0.053 | 0.384 | 0.171 | Interleukin 6 antagonist | 0.171 0.063 DBMET03347 0.164 0.071 DBMET03350 0.157 0.08 DBMET03352 | DBMET03347 | |
| 0.046 | 0.377 | 0.101 | Interleukin 12 antagonist | 0.099 0.056 DBMET03347 0.093 0.067 DBMET03350 0.101 0.053 DBMET03352 | DBMET03352 | |
| 0.005 | 0.356 | 0.044 | 1,3-Beta-glucan synthase inhibitor | 0.037 0.005 DBMET03346 0.037 0.005 DBMET03349 0.044 0.003 DBMET03351 | DBMET03351 | |
| 0.003 | 0.363 | 0.042 | Estrone sulfatase inhibitor | 0.042 0.008 DBMET03351 | DBMET03351 | |
| 0.062 | 0.428 | 0.448 | Immunosuppressant | 0.433 0.052 DBMET03347 0.433 0.052 DBMET03350 0.448 0.048 DBMET03352 | DBMET03352 | |
| 0.004 | 0.371 | 0.048 | Integrin alphaLbeta2 antagonist | 0.048 0.004 DBMET03340 | DBMET03340 | |
| 0.047 | 0.429 | 0.215 | Insulin secretagoues | 0.215 0.029 DBMET03347 0.201 0.035 DBMET03350 0.201 0.035 DBMET03352 | DBMET03347 | |
| 0.021 | 0.449 | 0.131 | Mcl-1 antagonist | 0.131 0.11 DBMET03343 | DBMET03343 | |
| 0.004 | 0.44 | 0.042 | Potassium channel subfamily K member 3 blocker | 0.042 0.014 DBMET03341 | DBMET03341 | |
| 0.026 | 0.47 | 0.556 | Anticoagulant | 0.401 0.016 DBMET03346 0.202 0.052 DBMET03347 0.556 0.007 DBMET03349 0.183 0.06 DBMET03350 0.488 0.01 DBMET03351 0.203 0.052 DBMET03352 | DBMET03349 | |
| 0.022 | 0.474 | 0.306 | Thrombolytic | 0.144 0.086 DBMET03346 0.306 0.023 DBMET03347 0.128 0.101 DBMET03349 0.242 0.036 DBMET03350 0.123 0.107 DBMET03351 0.278 0.028 DBMET03352 | DBMET03347 | |
| 0.013 | 0.476 | 0.093 | Thrombin inhibitor | 0.075 0.047 DBMET03346 0.076 0.047 DBMET03349 0.093 0.03 DBMET03351 | DBMET03351 | |
| 0.027 | 0.5 | 0.059 | Lipocortins synthesis agonist | 0.059 0.038 DBMET03347 0.059 0.038 DBMET03350 0.059 0.038 DBMET03352 | DBMET03352 | |
| 0.022 | 0.496 | 0.058 | Adenine nucleotide translocase inhibitor | 0.058 0.033 DBMET03347 0.058 0.033 DBMET03350 0.056 0.037 DBMET03352 | DBMET03350 | |
| 0.027 | 0.506 | 0.101 | DNA polymerase I inhibitor | 0.1 0.086 DBMET03344 0.101 0.085 DBMET03347 0.101 0.085 DBMET03350 | DBMET03350 | |
| 0.024 | 0.509 | 0.716 | Angiogenesis stimulant | 0.413 0.02 DBMET03346 0.716 0.004 DBMET03347 0.4 0.022 DBMET03349 0.574 0.008 DBMET03350 0.401 0.021 DBMET03351 0.593 0.007 DBMET03352 | DBMET03347 | |
| 0.077 | 0.581 | 0.138 | CC chemokine 6 receptor antagonist | 0.138 0.044 DBMET03347 0.138 0.044 DBMET03350 0.136 0.05 DBMET03352 | DBMET03350 | |
| 0.054 | 0.573 | 0.15 | Growth factor agonist | 0.15 0.141 DBMET03340 | DBMET03340 | |
| 0.005 | 0.528 | 0.036 | Protein 30S ribosomal subunit inhibitor | 0.036 0.011 DBMET03347 0.035 0.011 DBMET03350 0.035 0.011 DBMET03352 | DBMET03347 | |
| 0.011 | 0.571 | 0.066 | Antibiotic Aminoglycoside-like | 0.066 0.007 DBMET03347 0.066 0.007 DBMET03350 0.066 0.007 DBMET03352 | DBMET03352 | |
| 0.022 | 0.596 | 0.118 | Nav1.4 sodium channel blocker | 0.118 0.054 DBMET03339 | DBMET03339 | |
| 0.075 | 0.651 | 0.359 | Peptidyltransferase inhibitor | 0.359 0.011 DBMET03347 0.359 0.011 DBMET03350 0.355 0.011 DBMET03352 | DBMET03350 | |
| 0.009 | 0.593 | 0.206 | Cholecystokinin B agonist | 0.206 0.004 DBMET03346 0.206 0.004 DBMET03349 0.206 0.004 DBMET03351 | DBMET03351 | |
| 0.06 | 0.647 | 0.712 | Antiinflammatory | 0.712 0.029 DBMET03347 0.705 0.03 DBMET03350 0.273 0.241 DBMET03351 0.682 0.034 DBMET03352 | DBMET03347 | |
| 0.007 | 0.623 | 0.061 | Neuraminidase (influenza) inhibitor | 0.059 0.055 DBMET03347 0.061 0.052 DBMET03350 | DBMET03350 | |
| 0.033 | 0.682 | 0.207 | NOS3 expression enhancer | 0.207 0.038 DBMET03347 0.207 0.038 DBMET03350 0.196 0.042 DBMET03352 | DBMET03350 | |
| 0.062 | 0.725 | 0.37 | Interleukin 2 agonist | 0.37 0.037 DBMET03347 0.37 0.037 DBMET03350 0.37 0.037 DBMET03352 | DBMET03352 | |
| 0.004 | 0.688 | 0.304 | Selectin antagonist | 0.163 0.016 DBMET03346 0.304 0.005 DBMET03347 0.163 0.016 DBMET03349 0.304 0.005 DBMET03350 0.16 0.016 DBMET03351 0.303 0.005 DBMET03352 | DBMET03350 | |
| 0.005 | 0.697 | 0.107 | Elastase inhibitor | 0.067 0.024 DBMET03346 0.068 0.024 DBMET03349 0.107 0.008 DBMET03351 | DBMET03351 | |
| 0.003 | 0.695 | 0.041 | Factor XI inhibitor | 0.041 0.015 DBMET03351 | DBMET03351 | |
| 0.004 | 0.717 | 0.047 | Factor XIa inhibitor | 0.047 0.021 DBMET03351 | DBMET03351 | |
| 0.003 | 0.721 | 0.062 | Cholecystokinin A antagonist | 0.062 0.016 DBMET03346 0.062 0.016 DBMET03349 0.059 0.017 DBMET03351 | DBMET03349 | |
| 0.024 | 0.756 | 0.116 | Transcription factor NF kappa B stimulant | 0.104 0.036 DBMET03347 0.104 0.036 DBMET03350 0.116 0.027 DBMET03352 | DBMET03352 | |
| 0.003 | 0.743 | 0.038 | Cholecystokinin antagonist | 0.038 0.03 DBMET03346 0.038 0.03 DBMET03349 0.035 0.032 DBMET03351 | DBMET03349 | |
| 0.003 | 0.763 | 0.027 | Cholecystokinin B antagonist | 0.027 0.025 DBMET03346 0.027 0.025 DBMET03349 | DBMET03349 | |
| 0.007 | 0.769 | 0.155 | Hypolipemic | 0.155 0.132 DBMET03350 0.145 0.143 DBMET03352 | DBMET03350 | |
| 0.018 | 0.808 | 0.68 | Cyclophilin D inhibitor | 0.675 0.017 DBMET03347 0.68 0.016 DBMET03350 0.64 0.021 DBMET03352 | DBMET03350 | |
| 0.01 | 0.847 | 0.091 | Factor IXa inhibitor | 0.091 0.012 DBMET03346 0.048 0.041 DBMET03347 0.091 0.012 DBMET03349 0.048 0.041 DBMET03350 0.091 0.012 DBMET03351 0.048 0.041 DBMET03352 | DBMET03351 | |
| 0.013 | 0.861 | 0.251 | Immunomodulator | 0.248 0.117 DBMET03347 0.216 0.145 DBMET03350 0.251 0.114 DBMET03352 | DBMET03352 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |